{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T18:28:39Z","timestamp":1761848919087,"version":"build-2065373602"},"reference-count":369,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T00:00:00Z","timestamp":1750809600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T00:00:00Z","timestamp":1750809600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Saskatchewan Research Health Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"DOI":"10.1007\/s11255-025-04613-z","type":"journal-article","created":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T10:24:40Z","timestamp":1750847080000},"page":"4177-4208","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Molecular frontiers in hemodialysis: unraveling the role of membranes in gene expression, epigenetics, and inflammatory pathways"],"prefix":"10.1007","volume":"57","author":[{"given":"Hira","family":"Syeda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria","family":"Doan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Shoker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amira","family":"Abdelrasoul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,25]]},"reference":[{"key":"4613_CR1","unstructured":"Murdeshwar HN, Anjum F (2025) Hemodialysis. In: StatPearls. Treasure Island, FL: StatPearls Publishing. PMID: 33085443"},{"key":"4613_CR2","first-page":"116","volume":"3","author":"JS Eswari","year":"2020","unstructured":"Eswari JS, Naik S (2020) A critical analysis on various technologies and functionalized materials for manufacturing dialysis membranes. Mater Sci Energy Technol 3:116\u2013126","journal-title":"Mater Sci Energy Technol"},{"key":"4613_CR3","doi-asserted-by":"crossref","first-page":"100021","DOI":"10.1016\/j.bea.2021.100021","volume":"2","author":"H Westphalen","year":"2021","unstructured":"Westphalen H, Kalugin D, Abdelrasoul A (2021) Structure, function, and adsorption of highly abundant blood proteins and its critical influence on hemodialysis patients: a critical review. Biomed Eng Adv 2:100021","journal-title":"Biomed Eng Adv"},{"issue":"3","key":"4613_CR4","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3390\/membranes12030325","volume":"12","author":"Y Raharjo","year":"2022","unstructured":"Raharjo Y et al (2022) Dialysis membranes for acute kidney injury. Membranes 12(3):325","journal-title":"Membranes"},{"key":"4613_CR5","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/s10047-005-0303-2","volume":"8","author":"K-I Yamamoto","year":"2005","unstructured":"Yamamoto K-I et al (2005) Membrane fouling and dialysate flow pattern in an internal filtration-enhancing dialyzer. J Artif Organs 8:198\u2013205","journal-title":"J Artif Organs"},{"issue":"21","key":"4613_CR6","doi-asserted-by":"crossref","first-page":"4489","DOI":"10.3390\/nu14214489","volume":"14","author":"B Canaud","year":"2022","unstructured":"Canaud B et al (2022) Fluid overload and tissue sodium accumulation as main drivers of protein energy malnutrition in dialysis patients. Nutrients 14(21):4489","journal-title":"Nutrients"},{"key":"4613_CR7","doi-asserted-by":"crossref","unstructured":"Huang Z, Gao D, Letteri JJ, Clark WR (2009). Innovation in the treatment of uremia: proceedings from the cleveland clinic workshop: blood\u2013membrane interactions during dialysis. In: Seminars in dialysis,  (Vol. 22, No. 6, pp. 623\u2013628) Oxford, UK: Blackwell Publishing Ltd","DOI":"10.1111\/j.1525-139X.2009.00658.x"},{"issue":"1","key":"4613_CR8","doi-asserted-by":"crossref","first-page":"23080","DOI":"10.1038\/s41598-021-01660-1","volume":"11","author":"A Abdelrasoul","year":"2021","unstructured":"Abdelrasoul A et al (2021) Hemodialysis biocompatibility mathematical models to predict the inflammatory biomarkers released in dialysis patients based on hemodialysis membrane characteristics and clinical practices. Sci Rep 11(1):23080","journal-title":"Sci Rep"},{"issue":"4","key":"4613_CR9","doi-asserted-by":"crossref","first-page":"844","DOI":"10.3390\/biomedicines10040844","volume":"10","author":"M Bonomini","year":"2022","unstructured":"Bonomini M et al (2022) Biocompatibility of surface-modified membranes for chronic hemodialysis therapy. Biomedicines 10(4):844","journal-title":"Biomedicines"},{"issue":"10","key":"4613_CR10","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.3390\/cells8101209","volume":"8","author":"KM de la Harpe","year":"2019","unstructured":"de la Harpe KM et al (2019) The hemocompatibility of nanoparticles: a review of cell\u2013nanoparticle interactions and hemostasis. Cells 8(10):1209","journal-title":"Cells"},{"key":"4613_CR11","doi-asserted-by":"crossref","first-page":"100348","DOI":"10.1016\/j.colcom.2020.100348","volume":"40","author":"H Westphalen","year":"2021","unstructured":"Westphalen H, Abdelrasoul A, Shoker A (2021) Protein adsorption phenomena in hemodialysis membranes: mechanisms, influences of clinical practices, modeling, and challenges. Colloid Interface Sci Commun 40:100348","journal-title":"Colloid Interface Sci Commun"},{"key":"4613_CR12","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.cherd.2023.08.025","volume":"198","author":"M Mapiour","year":"2023","unstructured":"Mapiour M, Abdelrasoul A (2023) Model development and validation for human serum proteins-membrane interactions: membrane fouling applications in ultrafiltration of patients blood. Chem Eng Res Des 198:56\u201368","journal-title":"Chem Eng Res Des"},{"issue":"10","key":"4613_CR13","doi-asserted-by":"crossref","first-page":"3422","DOI":"10.3390\/ijms21103422","volume":"21","author":"V Losappio","year":"2020","unstructured":"Losappio V et al (2020) Molecular mechanisms of premature aging in hemodialysis: the complex interplay between innate and adaptive immune dysfunction. Int J Mol Sci 21(10):3422","journal-title":"Int J Mol Sci"},{"key":"4613_CR14","doi-asserted-by":"crossref","first-page":"105742","DOI":"10.1016\/j.cmpb.2020.105742","volume":"197","author":"A Mollahosseini","year":"2020","unstructured":"Mollahosseini A et al (2020) A case study of poly (aryl ether sulfone) hemodialysis membrane interactions with human blood: molecular dynamics simulation and experimental analyses. Comput Methods Progr Biomed 197:105742","journal-title":"Comput Methods Progr Biomed"},{"key":"4613_CR15","doi-asserted-by":"crossref","first-page":"100034","DOI":"10.1016\/j.bea.2022.100034","volume":"3","author":"A Mollahosseini","year":"2022","unstructured":"Mollahosseini A, Abdelrasoul A (2022) Novel insights in hemodialysis: most recent theories on membrane hemocompatibility improvement. Biomed Eng Adv 3:100034","journal-title":"Biomed Eng Adv"},{"key":"4613_CR16","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/978-3-031-17572-5_5","volume-title":"Management of Dysregulated Immune Response in the Critically Ill","author":"KK Ki","year":"2023","unstructured":"Ki KK, Heinsar S, Langguth D, Fraser JF (2023) Extracorporeal Circulation-Related Immune Response. Management of Dysregulated Immune Response in the Critically Ill. Springer International Publishing, Cham, pp 85\u2013112"},{"key":"4613_CR17","doi-asserted-by":"crossref","first-page":"118136","DOI":"10.1016\/j.seppur.2020.118136","volume":"259","author":"H Westphalen","year":"2021","unstructured":"Westphalen H et al (2021) Assessment of hemodialysis clinical practices using polyaryl ether sulfone-polyvinylpyrrolidone (PAES: PVP) clinical membrane: Modeling of in vitro fibrinogen adsorption, in situ synchrotron-based imaging, and clinical inflammatory biomarkers investigations. Sep Purif Technol 259:118136","journal-title":"Sep Purif Technol"},{"issue":"6","key":"4613_CR18","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.semnephrol.2013.08.001","volume":"33","author":"Marina Noris","year":"2013","unstructured":"Noris M, Remuzzi G (2013) Overview of Complement Activation and Regulation. Seminars in Nephrology 33(6):479\u2013492. https:\/\/doi.org\/10.1016\/j.semnephrol.2013.08.001","journal-title":"Seminars in Nephrology"},{"issue":"2","key":"4613_CR19","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1046\/j.1523-1755.1999.00273.x","volume":"55","author":"J Zimmermann","year":"1999","unstructured":"Zimmermann J et al (1999) Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 55(2):648\u2013658","journal-title":"Kidney Int"},{"key":"4613_CR20","doi-asserted-by":"crossref","first-page":"800950","DOI":"10.3389\/fphar.2022.800950","volume":"13","author":"Y Wang","year":"2022","unstructured":"Wang Y, Gao Lu (2022) Inflammation and cardiovascular disease associated with hemodialysis for end-stage renal disease. Front Pharmacol 13:800950","journal-title":"Front Pharmacol"},{"issue":"2","key":"4613_CR21","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3390\/bioengineering10020145","volume":"10","author":"T Lang","year":"2023","unstructured":"Lang T et al (2023) Hemodiafiltration: technical and medical insights. Bioengineering 10(2):145","journal-title":"Bioengineering"},{"key":"4613_CR22","doi-asserted-by":"crossref","first-page":"102183","DOI":"10.1016\/j.mtcomm.2021.102183","volume":"27","author":"U Eduok","year":"2021","unstructured":"Eduok U et al (2021) Recent developments, current challenges and future perspectives on cellulosic hemodialysis membranes for highly efficient clearance of uremic toxins. Mater Today Commun 27:102183","journal-title":"Mater Today Commun"},{"key":"4613_CR23","doi-asserted-by":"crossref","first-page":"100049","DOI":"10.1016\/j.bea.2022.100049","volume":"4","author":"A Abdelrasoul","year":"2022","unstructured":"Abdelrasoul A, Shoker A (2022) Influence of hydration shell of hemodialysis clinical membranes on surrogate biomarkers activation in uremic serum of dialysis patients. Biomed Eng Adv 4:100049","journal-title":"Biomed Eng Adv"},{"key":"4613_CR24","doi-asserted-by":"crossref","first-page":"918775","DOI":"10.3389\/fimmu.2022.918775","volume":"13","author":"ELG Pryzdial","year":"2022","unstructured":"Pryzdial ELG, Leatherdale A, Conway EM (2022) Coagulation and complement: key innate defense participants in a seamless web. Front Immunol 13:918775","journal-title":"Front Immunol"},{"key":"4613_CR25","doi-asserted-by":"crossref","unstructured":"Brennan FH, Lee JD, Ruitenberg MJ, Woodruff TM (2016) Therapeutic targeting of complement to modify disease course and improve outcomes in neurological conditions. In: Seminars in Immunology (Vol. 28, No. 3, pp. 292-308). Academic Press","DOI":"10.1016\/j.smim.2016.03.015"},{"key":"4613_CR26","doi-asserted-by":"publisher","unstructured":"Amara U et al. (2008) Interaction Between the Coagulation and Complement System. In: Lambris, J. (eds) Current Topics in Complement II. In: Advances in Experimental Medicine and Biology, vol 632. Springer, New York, NY. https:\/\/doi.org\/10.1007\/978-0-387-78952-1_6","DOI":"10.1007\/978-0-387-78952-1_6"},{"issue":"13","key":"4613_CR27","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1080\/10408398.2018.1437022","volume":"59","author":"PH Fenwick","year":"2019","unstructured":"Fenwick PH et al (2019) Lifestyle genomics and the metabolic syndrome: a review of genetic variants that influence response to diet and exercise interventions. Crit Rev Food Sci Nutr 59(13):2028\u20132039","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"4","key":"4613_CR28","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.semnephrol.2018.05.002","volume":"38","author":"JB Kopp","year":"2018","unstructured":"Kopp JB, Winkler CA (2018) Genetics, genomics, and precision medicine in end-stage kidney disease. Semi Nephrol 38(4):317\u2013324. https:\/\/doi.org\/10.1016\/j.semnephrol.2018.05.002","journal-title":"Semi Nephrol"},{"issue":"4","key":"4613_CR29","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.semnephrol.2013.05.008","volume":"33","author":"Maria R Wing","year":"2013","unstructured":"Wing MR, Ramezani A, Gill HS, Devaney JM, Raj DS (2013) Epigenetics of progression of chronic kidney disease: fact or fantasy? Semi Nephrol 33(4):363\u2013374. https:\/\/doi.org\/10.1016\/j.semnephrol.2013.05.008","journal-title":"Seminars in Nephrology"},{"issue":"4","key":"4613_CR30","doi-asserted-by":"crossref","first-page":"i59","DOI":"10.1093\/ckj\/sfab185","volume":"14","author":"SK Bowry","year":"2021","unstructured":"Bowry SK et al (2021) Blood-incompatibility in haemodialysis: alleviating inflammation and effects of coagulation. Clin Kidney J 14(4):i59\u2013i71","journal-title":"Clin Kidney J"},{"key":"4613_CR31","doi-asserted-by":"crossref","first-page":"122911","DOI":"10.1016\/j.matchemphys.2020.122911","volume":"248","author":"A Mollahosseini","year":"2020","unstructured":"Mollahosseini A, Abdelrasoul A, Shoker A (2020) A critical review of recent advances in hemodialysis membranes hemocompatibility and guidelines for future development. Mater Chem Phys 248:122911","journal-title":"Mater Chem Phys"},{"issue":"Suppl. 1","key":"4613_CR32","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000529971","volume":"52","author":"R Franzin","year":"2023","unstructured":"Franzin R et al (2023) Enhancing immune protection in hemodialysis patients: role of the polymethyl methacrylate membrane. Blood Purif 52(Suppl. 1):11\u201323","journal-title":"Blood Purif"},{"issue":"4","key":"4613_CR33","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.xkme.2021.04.006","volume":"3","author":"SC Skinner","year":"2021","unstructured":"Skinner SC et al (2021) Hemodialysis-related complement and contact pathway activation and cardiovascular risk: a narrative review. Kidney Med 3(4):607\u2013618","journal-title":"Kidney Med"},{"issue":"2","key":"4613_CR34","doi-asserted-by":"crossref","first-page":"379","DOI":"10.2215\/CJN.03490708","volume":"4","author":"M Bossola","year":"2009","unstructured":"Bossola M et al (2009) Circulating bacterial-derived DNA fragments and markers of inflammation in chronic hemodialysis patients. Clin J Am Soc Nephrol 4(2):379\u2013385","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"4613_CR35","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1080\/08860220902963673","volume":"31","author":"S Opatrna","year":"2009","unstructured":"Opatrna S et al (2009) Cell-free plasma DNA during hemodialysis. Ren Fail 31(6):475\u2013480","journal-title":"Ren Fail"},{"key":"4613_CR36","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1111\/sdi.12573","volume":"30","author":"RL McGill","year":"2017","unstructured":"McGill RL, Weiner DE (2017) Dialysate composition for hemodialysis: changes and changing risk. Semin Dial 30:112\u2013120. https:\/\/doi.org\/10.1111\/sdi.12573","journal-title":"Semin Dial"},{"issue":"10","key":"4613_CR37","doi-asserted-by":"crossref","first-page":"932","DOI":"10.3390\/membranes12100932","volume":"12","author":"AM Zawada","year":"2022","unstructured":"Zawada AM et al (2022) Impact of hydrophilic modification of synthetic dialysis membranes on hemocompatibility and performance. Membranes 12(10):932","journal-title":"Membranes"},{"key":"4613_CR38","unstructured":"Haney P, Herting K, Smith S (2013) Molecular weight cut-off (MWCO) specifications and rates of buffer exchange with Slide-A-Lyzer dialysis devices and snakeskin dialysis tubing. Protein Biology Resource Library, ThermoFisher Scientific, Waltam"},{"issue":"2","key":"4613_CR39","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2144\/btn-2018-0133","volume":"66","author":"SJW Krerowicz","year":"2019","unstructured":"Krerowicz SJW, Hernandez-Ortiz JP, Schwartz DC (2019) A simple dialysis device for large DNA molecules. Biotechniques 66(2):93\u201395","journal-title":"Biotechniques"},{"issue":"3","key":"4613_CR40","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/hdi.12008","volume":"17","author":"C Ersson","year":"2013","unstructured":"Ersson C et al (2013) The effects of hemodialysis treatment on the level of DNA strand breaks and oxidative DNA lesions measured by the comet assay. Hemodial Int 17(3):366\u2013373","journal-title":"Hemodial Int"},{"issue":"7","key":"4613_CR41","doi-asserted-by":"crossref","first-page":"811","DOI":"10.3390\/genes11070811","volume":"11","author":"D Ingrosso","year":"2020","unstructured":"Ingrosso D, Perna AF (2020) DNA methylation dysfunction in chronic kidney disease. Genes 11(7):811","journal-title":"Genes"},{"key":"4613_CR42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mrgentox.2016.07.008","volume":"808","author":"Z Corredor","year":"2016","unstructured":"Corredor Z et al (2016) Levels of DNA damage in peripheral blood lymphocytes of patients undergoing standard hemodialysis vs on-line hemodiafiltration: a comet assay investigation. Mutat Res Genet Toxicol Environ Mutagen 808:1\u20137","journal-title":"Mutat Res Genet Toxicol Environ Mutagen"},{"issue":"2","key":"4613_CR43","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/mutage\/gev063","volume":"31","author":"L Rodr\u00edguez-Ribera","year":"2016","unstructured":"Rodr\u00edguez-Ribera L et al (2016) Genetic damage in patients moving from hemodialysis to online hemodiafiltration. Mutagenesis 31(2):131\u2013135","journal-title":"Mutagenesis"},{"issue":"1","key":"4613_CR44","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3390\/toxics12010069","volume":"12","author":"Y Y\u00fczba\u015f\u0131o\u011flu","year":"2024","unstructured":"Y\u00fczba\u015f\u0131o\u011flu Y et al (2024) Biomonitoring of oxidative-stress-related genotoxic damage in patients with end-stage renal disease. Toxics 12(1):69","journal-title":"Toxics"},{"key":"4613_CR45","doi-asserted-by":"crossref","first-page":"205435812311541","DOI":"10.1177\/20543581231154185","volume":"10","author":"TM Kitzler","year":"2023","unstructured":"Kitzler TM, Chun J (2023) Understanding the current landscape of kidney disease in canada to advance precision medicine guided personalized care. Can J Kidney Health Dis 10:20543581231154184","journal-title":"Can J Kidney Health Dis"},{"issue":"7","key":"4613_CR46","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/s41581-023-00702-3","volume":"19","author":"JL Peek","year":"2023","unstructured":"Peek JL, Wilson MH (2023) Cell and gene therapy for kidney disease. Nat Rev Nephrol 19(7):451\u2013462","journal-title":"Nat Rev Nephrol"},{"key":"4613_CR47","doi-asserted-by":"crossref","first-page":"205435811988266","DOI":"10.1177\/2054358119882664","volume":"6","author":"B Imbeault","year":"2019","unstructured":"Imbeault B, Nadeau-Fredette A-C (2019) Optimization of dialysis modality transitions for improved patient care. Can J Kidney Health Dis 6:2054358119882664","journal-title":"Can J Kidney Health Dis"},{"issue":"4","key":"4613_CR48","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1007\/s42765-023-00277-5","volume":"5","author":"H Ji","year":"2023","unstructured":"Ji H et al (2023) Advances in enhancing hemocompatibility of hemodialysis hollow-fiber membranes. Adv fiber mater 5(4):1198\u20131240","journal-title":"Adv fiber mater"},{"key":"4613_CR49","doi-asserted-by":"publisher","unstructured":"Alonso A, Lau J, Jaber BL (2008) Biocompatible hemodialysis membranes for acute renal failure. Cochrane Database Syst Rev 2008(1):CD005283. https:\/\/doi.org\/10.1002\/14651858.CD005283.pub2. Accessed 23 June 2025.","DOI":"10.1002\/14651858.CD005283.pub2"},{"issue":"2","key":"4613_CR50","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1159\/000170153","volume":"12","author":"A Gutierrez","year":"1994","unstructured":"Gutierrez A et al (1994) Biocompatibility of hemodialysis membranes: a study in healthy subjects. Blood Purif 12(2):95\u2013105","journal-title":"Blood Purif"},{"issue":"2","key":"4613_CR51","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3390\/membranes12020152","volume":"12","author":"Y-A Chen","year":"2022","unstructured":"Chen Y-A, Shuo-Ming Ou, Lin C-C (2022) Influence of dialysis membranes on clinical outcomes: from history to innovation. Membranes 12(2):152","journal-title":"Membranes"},{"issue":"6","key":"4613_CR52","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1039\/C5MB00058K","volume":"11","author":"L Pieroni","year":"2015","unstructured":"Pieroni L et al (2015) Biocompatibility assessment of haemodialysis membrane materials by proteomic investigations. Mol BioSyst 11(6):1633\u20131643","journal-title":"Mol BioSyst"},{"key":"4613_CR53","doi-asserted-by":"crossref","first-page":"135626","DOI":"10.1016\/j.chemosphere.2022.135626","volume":"307","author":"SU Zaman","year":"2022","unstructured":"Zaman SU et al (2022) Recent advancement challenges with synthesis of biocompatible hemodialysis membranes. Chemosphere 307:135626","journal-title":"Chemosphere"},{"issue":"11","key":"4613_CR54","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.3390\/membranes12111063","volume":"12","author":"S Nazari","year":"2022","unstructured":"Nazari S, Abdelrasoul A (2022) Impact of membrane modification and surface immobilization techniques on the hemocompatibility of hemodialysis membranes: a critical review. Membranes 12(11):1063","journal-title":"Membranes"},{"key":"4613_CR55","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.msec.2015.06.035","volume":"56","author":"M Irfan","year":"2015","unstructured":"Irfan M, Idris A (2015) Overview of PES biocompatible\/hemodialysis membranes: PES\u2013blood interactions and modification techniques. Mater Sci Eng, C 56:574\u2013592","journal-title":"Mater Sci Eng, C"},{"issue":"1","key":"4613_CR56","doi-asserted-by":"crossref","first-page":"57","DOI":"10.17219\/pim\/102974","volume":"48","author":"P Olczyk","year":"2018","unstructured":"Olczyk P, Ma\u0142yszczak A, Kusztal M (2018) Dialysis membranes a 2018 update. Polim Med 48(1):57\u201363","journal-title":"Polim Med"},{"issue":"1\u20132","key":"4613_CR57","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.memsci.2007.08.030","volume":"305","author":"A Rahimpour","year":"2007","unstructured":"Rahimpour A, Madaeni SS (2007) Polyethersulfone (PES)\/cellulose acetate phthalate (CAP) blend ultrafiltration membranes: preparation, morphology, performance and antifouling properties. J Membr Sci 305(1\u20132):299\u2013312","journal-title":"J Membr Sci"},{"issue":"4","key":"4613_CR58","first-page":"117","volume":"2","author":"AC Yamashita","year":"2021","unstructured":"Yamashita AC, Togo K (2021) Blood Compatibility in Various Hemodialysis Membrane Materials: A Review. J Clin Haematol 2(4):117\u2013120","journal-title":"J Clin Haematol"},{"issue":"1","key":"4613_CR59","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3390\/membranes12010030","volume":"12","author":"NH Othman","year":"2021","unstructured":"Othman NH et al (2021) A review on the use of membrane technology systems in developing countries. Membranes 12(1):30","journal-title":"Membranes"},{"key":"4613_CR60","doi-asserted-by":"crossref","first-page":"100026","DOI":"10.1016\/j.bea.2022.100026","volume":"3","author":"S Nazari","year":"2022","unstructured":"Nazari S, Abdelrasoul A (2022) Surface zwitterionization of hemodialysismembranesfor hemocompatibility enhancement and protein-mediated anti-adhesion: a critical review. Biomed Eng Adv 3:100026","journal-title":"Biomed Eng Adv"},{"issue":"7","key":"4613_CR61","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/aor.13887","volume":"45","author":"P Melchior","year":"2021","unstructured":"Melchior P et al (2021) Complement activation by dialysis membranes and its association with secondary membrane formation and surface charge. Artif Organs 45(7):770\u2013778","journal-title":"Artif Organs"},{"issue":"22","key":"4613_CR62","doi-asserted-by":"crossref","first-page":"4099","DOI":"10.3390\/molecules24224099","volume":"24","author":"N Arahman","year":"2019","unstructured":"Arahman N et al (2019) Improving water permeability of hydrophilic PVDF membrane prepared via blending with organic and inorganic additives for humic acid separation. Molecules 24(22):4099","journal-title":"Molecules"},{"key":"4613_CR63","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.colsurfb.2017.09.038","volume":"160","author":"X Cui","year":"2017","unstructured":"Cui X et al (2017) Anti-biofouling phosphorylated HEMA and PEGMA block copolymers show high affinity to hydroxyapatite. Colloids Surf B 160:289\u2013296","journal-title":"Colloids Surf B"},{"issue":"12","key":"4613_CR64","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3390\/bioengineering8120215","volume":"8","author":"J Kuchinka","year":"2021","unstructured":"Kuchinka J et al (2021) Control of blood coagulation by hemocompatible material surfaces\u2014a review. Bioengineering 8(12):215","journal-title":"Bioengineering"},{"key":"4613_CR65","first-page":"7","volume":"36","author":"SP Mitra","year":"2020","unstructured":"Mitra SP (2020) Protein adsorption on biomaterial surfaces: subsequent conformational and biological consequences\u2014a review. J Surf Sci Technol 36:7\u201338","journal-title":"J Surf Sci Technol"},{"issue":"1\u20132","key":"4613_CR66","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0376-7388(03)00313-2","volume":"222","author":"S Sun","year":"2003","unstructured":"Sun S et al (2003) Protein adsorption on blood-contact membranes. J Membr Sci 222(1\u20132):3\u201318","journal-title":"J Membr Sci"},{"key":"4613_CR67","first-page":"306","volume":"10","author":"DF Williams","year":"2022","unstructured":"Williams DF (2022) Biocompatibility pathways and mechanisms for bioactive materials: the bioactivity zone. Bioact Mater 10:306\u2013322","journal-title":"Bioact Mater"},{"issue":"8","key":"4613_CR68","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1016\/j.actbio.2009.04.011","volume":"5","author":"A Floridi","year":"2009","unstructured":"Floridi A et al (2009) Analysis method and characterization of the antioxidant capacity of vitamin E-interactive polysulfone hemodialyzers. Acta Biomater 5(8):2974\u20132982","journal-title":"Acta Biomater"},{"issue":"3","key":"4613_CR69","doi-asserted-by":"crossref","first-page":"e21764","DOI":"10.17795\/nmsjournal21764","volume":"3","author":"K Oshvandi","year":"2014","unstructured":"Oshvandi K et al (2014) High-flux and low-flux membranes: efficacy in hemodialysis. Nurs midwifery stud 3(3):e21764","journal-title":"Nurs midwifery stud"},{"issue":"1","key":"4613_CR70","doi-asserted-by":"crossref","first-page":"20616","DOI":"10.1038\/s41598-021-99834-4","volume":"11","author":"M Abe","year":"2021","unstructured":"Abe M et al (2021) Dialyzer surface area is a significant predictor of mortality in patients on hemodialysis: a 3-year nationwide cohort study. Sci Rep 11(1):20616","journal-title":"Sci Rep"},{"issue":"2","key":"4613_CR71","doi-asserted-by":"crossref","first-page":"I","DOI":"10.1159\/000476012","volume":"44","author":"C Ronco","year":"2017","unstructured":"Ronco C (2017) The rise of expanded hemodialysis. Blood Purif 44(2):I\u2013VIII","journal-title":"Blood Purif"},{"issue":"suppl_1","key":"4613_CR72","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1681\/ASN.V13suppl_1s53","volume":"13","author":"C Ronco","year":"2002","unstructured":"Ronco C et al (2002) Blood and dialysate flow distributions in hollow-fiber hemodialyzers analyzed by computerized helical scanning technique. J Am Soc Nephrol 13(suppl_1):S53\u2013S61","journal-title":"J Am Soc Nephrol"},{"issue":"Suppl. 1","key":"4613_CR73","first-page":"19","volume":"51","author":"S Lee","year":"2022","unstructured":"Lee S, Sirich TL, Meyer TW (2022) Improving solute clearances by hemodialysis. Blood Purif 51(Suppl. 1):19\u201330","journal-title":"Blood Purif"},{"key":"4613_CR74","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000328940","volume":"173","author":"M Matsuda","year":"2011","unstructured":"Matsuda M, Sakai K (2011) Solute removal efficiency and biocompatibility of the high-performance membrane\u2013from engineering points of view. High perform membr dialyzers 173:11\u201322","journal-title":"High perform membr dialyzers"},{"issue":"5","key":"4613_CR75","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1053\/ajkd.2001.28580","volume":"38","author":"DRM Hassell","year":"2001","unstructured":"Hassell DRM et al (2001) Optimizing dialysis dose by increasing blood flow rate in patients with reduced vascular-access flow rate. Am J Kidney Dis 38(5):948\u2013955","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"4613_CR76","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.3904\/kjim.2015.111","volume":"31","author":"KY Chang","year":"2016","unstructured":"Chang KY et al (2016) The impact of blood flow rate during hemodialysis on all-cause mortality. Korean J Intern Med 31(6):1131","journal-title":"Korean J Intern Med"},{"issue":"2","key":"4613_CR77","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1272\/jnms.80.119","volume":"80","author":"T Kashiwagi","year":"2013","unstructured":"Kashiwagi T et al (2013) Effects of reduced dialysis fluid flow in hemodialysis. J Nippon Med Sch 80(2):119\u2013130","journal-title":"J Nippon Med Sch"},{"key":"4613_CR78","doi-asserted-by":"crossref","first-page":"111035","DOI":"10.1016\/j.micromeso.2021.111035","volume":"319","author":"Y Ma","year":"2021","unstructured":"Ma Y et al (2021) Adsorption-based strategies for removing uremic toxins from blood. Microporous Mesoporous Mater 319:111035","journal-title":"Microporous Mesoporous Mater"},{"issue":"5","key":"4613_CR79","first-page":"545","volume":"19","author":"GM Gagliardi","year":"2002","unstructured":"Gagliardi GM et al (2002) The measurement of vascular access recirculation and intra-access pressure in arteriovenous fistula monitoring in hemodialysis. Giornale Italiano di Nefrologia: Organo Ufficiale Della Societa Italiana di Nefrologia 19(5):545\u2013551","journal-title":"Giornale Italiano di Nefrologia: Organo Ufficiale Della Societa Italiana di Nefrologia"},{"issue":"5","key":"4613_CR80","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1093\/ckj\/sfv057","volume":"8","author":"F Locatelli","year":"2015","unstructured":"Locatelli F et al (2015) Optimizing haemodialysate composition. Clin Kidney J 8(5):580\u2013589","journal-title":"Clin Kidney J"},{"issue":"4","key":"4613_CR81","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1093\/ndt\/gfh102","volume":"19","author":"F Locatelli","year":"2004","unstructured":"Locatelli F et al (2004) Optimal composition of the dialysate, with emphasis on its influence on blood pressure. Nephrol Dial Transpl 19(4):785\u2013796","journal-title":"Nephrol Dial Transpl"},{"issue":"6","key":"4613_CR82","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.5301\/jn.5000236","volume":"26","author":"C Basile","year":"2013","unstructured":"Basile C et al (2013) Sodium setpoint and gradient in bicarbonate hemodialysis. J Nephrol 26(6):1136\u20131142","journal-title":"J Nephrol"},{"issue":"2","key":"4613_CR83","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1177\/0115426505020002192","volume":"20","author":"L Nanovic","year":"2005","unstructured":"Nanovic L (2005) Electrolytes and fluid management in hemodialysis and peritoneal dialysis. Nutr Clin Pract 20(2):192\u2013201","journal-title":"Nutr Clin Pract"},{"issue":"1","key":"4613_CR84","doi-asserted-by":"crossref","first-page":"sfad210","DOI":"10.1093\/ckj\/sfad210","volume":"17","author":"RG Dilaver","year":"2024","unstructured":"Dilaver RG, Alp Ikizler T (2024) Personalizing electrolytes in the dialysis prescription: what, why and how? Clin Kidney J 17(1):sfad210","journal-title":"Clin Kidney J"},{"key":"4613_CR85","doi-asserted-by":"publisher","unstructured":"Palmer BF (2001) Individualizing the dialysate in the hemodialysis patient. In Seminars in dialysis. (Vol. 14, No. 1, pp. 41-49). Boston, MA, USA: Blackwell Science Inc. https:\/\/doi.org\/10.1046\/j.1525-139x.2001.00013.x","DOI":"10.1046\/j.1525-139x.2001.00013.x"},{"key":"4613_CR86","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1590\/2175-8239-jbn-2019-0135","volume":"41","author":"B Canaud","year":"2019","unstructured":"Canaud B et al (2019) Fluid and hemodynamic management in hemodialysis patients: challenges and opportunities. Braz J Nephrol 41:550\u2013559","journal-title":"Braz J Nephrol"},{"key":"4613_CR87","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s11897-017-0356-6","volume":"14","author":"JA Chou","year":"2017","unstructured":"Chou JA, Kalantar-Zadeh K (2017) Volume balance and intradialytic ultrafiltration rate in the hemodialysis patient. Curr Heart Fail Rep 14:421\u2013427","journal-title":"Curr Heart Fail Rep"},{"issue":"6","key":"4613_CR88","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1093\/ckj\/sfaa078","volume":"13","author":"M Kanbay","year":"2020","unstructured":"Kanbay M et al (2020) An update review of intradialytic hypotension: concept, risk factors, clinical implications and management. Clin Kidney J 13(6):981\u2013993","journal-title":"Clin Kidney J"},{"key":"4613_CR89","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1745-6215-15-1","volume":"15","author":"KCW Leung","year":"2014","unstructured":"Leung KCW et al (2014) Ultrafiltration biofeedback guided by blood volume monitoring to reduce intradialytic hypotensive episodes in hemodialysis: study protocol for a randomized controlled trial. Trials 15:1\u20139","journal-title":"Trials"},{"issue":"12","key":"4613_CR90","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1093\/ndt\/gfm466","volume":"22","author":"E Movilli","year":"2007","unstructured":"Movilli E et al (2007) Association between high ultrafiltration rates and mortality in uraemic patients on regular haemodialysis. A 5-year prospective observational multicentre study. Nephrol Dial Transpl 22(12):3547\u20133552","journal-title":"Nephrol Dial Transpl"},{"issue":"6","key":"4613_CR91","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1053\/j.ajkd.2016.06.020","volume":"68","author":"MM Assimon","year":"2016","unstructured":"Assimon MM et al (2016) Ultrafiltration rate and mortality in maintenance hemodialysis patients. Am J Kidney Dis 68(6):911\u2013922","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"4613_CR92","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/ki.2010.383","volume":"79","author":"JE Flythe","year":"2011","unstructured":"Flythe JE, Kimmel SE, Brunelli SM (2011) Rapid fluid removal during dialysis is associated with cardiovascular morbidity and mortality. Kidney Int 79(2):250\u2013257","journal-title":"Kidney Int"},{"key":"4613_CR93","doi-asserted-by":"crossref","first-page":"100415","DOI":"10.1016\/j.conctc.2019.100415","volume":"15","author":"MJ Tugman","year":"2019","unstructured":"Tugman MJ et al (2019) Ultrafiltration-profiled hemodialysis to reduce dialysis-related cardiovascular stress: Study protocol for a randomized controlled trial. Contemp Clin Trials Commun 15:100415","journal-title":"Contemp Clin Trials Commun"},{"issue":"3","key":"4613_CR94","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S0085-2538(15)46393-8","volume":"56","author":"D Yarar","year":"1999","unstructured":"Yarar D et al (1999) Ultrafiltration method for measuring vascular access flow rates during hemodialysis. Kidney Int 56(3):1129\u20131135","journal-title":"Kidney Int"},{"key":"4613_CR95","doi-asserted-by":"publisher","unstructured":"Miller JL, Grant PA (2013) The Role of DNA Methylation and Histone Modifications in Transcriptional Regulation in Humans. In: Kundu T (eds) Epigenetics: Development and Disease. Subcellular Biochemistry, vol 61. Springer, Dordrecht. https:\/\/doi.org\/10.1007\/978-94-007-4525-4_13","DOI":"10.1007\/978-94-007-4525-4_13"},{"issue":"17","key":"4613_CR96","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1089\/ars.2020.8184","volume":"35","author":"T Ebert","year":"2021","unstructured":"Ebert T et al (2021) Inflammation and oxidative stress in chronic kidney disease and dialysis patients. Antioxid Redox Signal 35(17):1426\u20131448","journal-title":"Antioxid Redox Signal"},{"issue":"11","key":"4613_CR97","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1093\/ndt\/gfy009","volume":"33","author":"M Fontecha-Barriuso","year":"2018","unstructured":"Fontecha-Barriuso M et al (2018) Targeting epigenetic DNA and histone modifications to treat kidney disease. Nephrol Dial Transplant 33(11):1875\u20131886","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"4613_CR98","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/1744-9987.12238","volume":"19","author":"A-B Ghigolea","year":"2015","unstructured":"Ghigolea A-B, Moldovan RA, Gherman-Caprioara M (2015) DNA methylation: hemodialysis versus hemodiafiltration. Ther Apher Dial 19(2):119\u2013124","journal-title":"Ther Apher Dial"},{"key":"4613_CR99","doi-asserted-by":"publisher","unstructured":"Hesham E, Magdy E, Waleed T, Hussein S, Mohammed K, Walid A, (2018) FP438STUDY of the effects of hemodiafiltration versus hemodialysis on Dna methylation and indoxyl sulfate removal, Nephrol Dialysis Transplant 33(suppl_1):182. https:\/\/doi.org\/10.1093\/ndt\/gfy104.FP438","DOI":"10.1093\/ndt\/gfy104.FP438"},{"key":"4613_CR100","unstructured":"Alberts B, Johnson A, Lewis J, Walter P, Raff M, Roberts K  (2002) Molecular Biology of the Cell 4th Edition: International Student Edition Routledge"},{"issue":"1","key":"4613_CR101","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/molbev\/msv228","volume":"33","author":"A Rodr\u00edguez-Verdugo","year":"2016","unstructured":"Rodr\u00edguez-Verdugo A, Tenaillon O, Gaut BS (2016) First-step mutations during adaptation restore the expression of hundreds of genes. Mol Biol Evol 33(1):25\u201339","journal-title":"Mol Biol Evol"},{"issue":"11","key":"4613_CR102","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1038\/s41591-018-0194-4","volume":"24","author":"C Qiu","year":"2018","unstructured":"Qiu C et al (2018) Renal compartment\u2013specific genetic variation analyses identify new pathways in chronic kidney disease. Nat Med 24(11):1721\u20131731","journal-title":"Nat Med"},{"key":"4613_CR103","doi-asserted-by":"crossref","unstructured":"Ye H, Ding H, Gan W, Wen P, Zhou Y, Cao H, He W (2019) Hemodialysis. In Chronic Kidney Disease: Diagnosis and Treatment (pp. 209\u2013231). Singapore: Springer Singapore","DOI":"10.1007\/978-981-32-9131-7_17"},{"key":"4613_CR104","doi-asserted-by":"crossref","unstructured":"Masi\u00e0-Plana, A., Alhameedi, R. (2024). Kidney Replacement Therapies: Hemodialysis. In: Masi\u00e0-Plana, A., Liossatou, A. (eds) Principles of Nursing in Kidney Care. Principles of Specialty Nursing. Springer, Cham. https:\/\/doi.org\/10.1007\/978-3-031-30320-3_7","DOI":"10.1007\/978-3-031-30320-3"},{"issue":"4","key":"4613_CR105","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.ekir.2024.01.027","volume":"9","author":"T Fujimaru","year":"2024","unstructured":"Fujimaru T et al (2024) Genetic diagnosis of adult hemodialysis patients with unknown etiology. Kidney Int Rep 9(4):994\u20131004","journal-title":"Kidney Int Rep"},{"issue":"1","key":"4613_CR106","doi-asserted-by":"crossref","first-page":"e0261829","DOI":"10.1371\/journal.pone.0261829","volume":"17","author":"C Sotomayor-Vivas","year":"2022","unstructured":"Sotomayor-Vivas C, Hern\u00e1ndez-Lemus E, Dorantes-Gilardi R (2022) Linking protein structural and functional change to mutation using amino acid networks. PLoS ONE 17(1):e0261829","journal-title":"PLoS ONE"},{"issue":"1","key":"4613_CR107","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1681\/ASN.2007091031","volume":"20","author":"M Rao","year":"2009","unstructured":"Rao M et al (2009) Mitochondrial DNA injury and mortality in hemodialysis patients. J Am Soc Nephrol 20(1):189\u2013196","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"4613_CR108","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.kint.2021.05.037","volume":"100","author":"R Mehrotra","year":"2021","unstructured":"Mehrotra R et al (2021) A genome-wide association study suggests correlations of common genetic variants with peritoneal solute transfer rates in patients with kidney failure receiving peritoneal dialysis. Kidney Int 100(5):1101\u20131111","journal-title":"Kidney Int"},{"key":"4613_CR109","doi-asserted-by":"crossref","first-page":"205435811878936","DOI":"10.1177\/2054358118789368","volume":"5","author":"V Kalatharan","year":"2018","unstructured":"Kalatharan V, Lemaire M, Lanktree MB (2018) Opportunities and challenges for genetic studies of end-stage renal disease in Canada. Can J Kidney Health Dis 5:2054358118789368","journal-title":"Can J Kidney Health Dis"},{"issue":"6","key":"4613_CR110","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.3390\/ijms18061248","volume":"18","author":"A Gluba-Brz\u00f3zka","year":"2017","unstructured":"Gluba-Brz\u00f3zka A et al (2017) Personalized medicine: new perspectives for the diagnosis and the treatment of renal diseases. Int J Mol Sci 18(6):1248","journal-title":"Int J Mol Sci"},{"issue":"11","key":"4613_CR111","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1681\/ASN.2010121234","volume":"22","author":"Z Kanji","year":"2011","unstructured":"Kanji Z et al (2011) Genetic variation in APOL1 associates with younger age at hemodialysis initiation. J Am Soc Nephrol 22(11):2091\u20132097","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"4613_CR112","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s12603-022-1778-8","volume":"26","author":"X Chen","year":"2022","unstructured":"Chen X et al (2022) Mediating effects of malnutrition on the relationship between depressive symptoms clusters and muscle function rather than muscle mass in older hemodialysis patients. J Nutr Health Aging 26(5):461\u2013468","journal-title":"J Nutr Health Aging"},{"issue":"10","key":"4613_CR113","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1080\/13548506.2019.1612074","volume":"24","author":"AG Markaki","year":"2019","unstructured":"Markaki AG et al (2019) Nutritional status in hemodialysis patients is inversely related to depression and introversion. Psychol Health Med 24(10):1213\u20131219","journal-title":"Psychol Health Med"},{"issue":"6","key":"4613_CR114","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/j.1440-1797.2006.00664.x","volume":"11","author":"H Micozkadioglu","year":"2006","unstructured":"Micozkadioglu H et al (2006) Relationship between depressive affect and malnutrition-inflammation complex syndrome in haemodialysis patients. Nephrology 11(6):502\u2013505","journal-title":"Nephrology"},{"issue":"5","key":"4613_CR115","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S0272-6386(03)00201-4","volume":"41","author":"J-R Koo","year":"2003","unstructured":"Koo J-R et al (2003) Association of depression with malnutrition in chronic hemodialysis patients. Am J Kidney Dis 41(5):1037\u20131042","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"4613_CR116","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.3390\/ijerph20032285","volume":"20","author":"M Vu\u010dkovi\u0107","year":"2023","unstructured":"Vu\u010dkovi\u0107 M et al (2023) Body composition parameters correlate to depression symptom levels in patients treated with hemodialysis and peritoneal dialysis. Int J Environ Res Public Health 20(3):2285","journal-title":"Int J Environ Res Public Health"},{"issue":"9","key":"4613_CR117","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.3390\/jpm13091311","volume":"13","author":"De la Cruz-Ahumada","year":"2023","unstructured":"la Cruz-Ahumada De, Jackelin C et al (2023) Inflammatory determinants and associated morbidity in hemodialysis patients. J Personalized Med 13(9):1311","journal-title":"J Personalized Med"},{"issue":"2","key":"4613_CR118","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3858\/emm.2008.40.2.161","volume":"40","author":"K-H Jeong","year":"2008","unstructured":"Jeong K-H et al (2008) Polymorphisms in two genes, IL-1B and ACE, are associated with erythropoietin resistance in Korean patients on maintenance hemodialysis. Exp Mol Med 40(2):161\u2013166","journal-title":"Exp Mol Med"},{"issue":"6","key":"4613_CR119","doi-asserted-by":"crossref","first-page":"166","DOI":"10.5527\/wjn.v1.i6.166","volume":"1","author":"E Canavesi","year":"2012","unstructured":"Canavesi E et al (2012) Hepcidin and HFE protein: iron metabolism as a target for the anemia of chronic kidney disease. World J Nephrol 1(6):166","journal-title":"World J Nephrol"},{"issue":"2","key":"4613_CR120","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1053\/j.ackd.2008.01.013","volume":"15","author":"M Amato","year":"2008","unstructured":"Amato M et al (2008) Iron indices and vitamin D receptor polymorphisms in hemodialysis patients. Adv Chronic Kidney Dis 15(2):186\u2013190","journal-title":"Adv Chronic Kidney Dis"},{"issue":"1","key":"4613_CR121","first-page":"19","volume":"51","author":"S Ram","year":"2003","unstructured":"Ram S et al (2003) Tumor necrosis factor-\u03b1-308 gene polymorphism is associated with synthetic hemodialysis graft failure. J Investig Med 51(1):19\u201326","journal-title":"J Investig Med"},{"issue":"3","key":"4613_CR122","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1681\/ASN.2005050465","volume":"17","author":"Y Liu","year":"2006","unstructured":"Liu Y et al (2006) IL-6 haplotypes, inflammation, and risk for cardiovascular disease in a multiethnic dialysis cohort. J Am Soc Nephrol 17(3):863\u2013870","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"4613_CR123","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/aje\/kwj347","volume":"165","author":"S Gilbody","year":"2007","unstructured":"Gilbody S, Lewis S, Lightfoot T (2007) Methylenetetrahydrofolate reductase (MTHFR) genetic polymorphisms and psychiatric disorders: a HuGE review. Am J Epidemiol 165(1):1\u201313","journal-title":"Am J Epidemiol"},{"issue":"1","key":"4613_CR124","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.gene.2016.09.034","volume":"595","author":"L-J Liu","year":"2016","unstructured":"Liu L-J et al (2016) Correlations of PTEN genetic polymorphisms with the risk of depression and depressive symptoms in a Chinese population. Gene 595(1):77\u201382","journal-title":"Gene"},{"issue":"2","key":"4613_CR125","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ajhg.2010.07.011","volume":"87","author":"SR Williams","year":"2010","unstructured":"Williams SR et al (2010) Haploinsufficiency of HDAC4 causes brachydactyly mental retardation syndrome, with brachydactyly type E, developmental delays, and behavioral problems. Am J Hum Genet 87(2):219\u2013228","journal-title":"Am J Hum Genet"},{"issue":"4","key":"4613_CR126","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1159\/000509908","volume":"80","author":"X Guan","year":"2021","unstructured":"Guan X et al (2021) Possible involvement of the IL-6\/JAK2\/STAT3 pathway in the hypothalamus in depressive-like behavior of rats exposed to chronic mild stress. Neuropsychobiology 80(4):279\u2013287","journal-title":"Neuropsychobiology"},{"issue":"5","key":"4613_CR127","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1177\/1535370215619707","volume":"241","author":"MM Al-Samhari","year":"2016","unstructured":"Al-Samhari MM et al (2016) Possible involvement of the JAK\/STAT signaling pathway in N-acetylcysteine-mediated antidepressant-like effects. Exp Biol Med 241(5):509\u2013518","journal-title":"Exp Biol Med"},{"key":"4613_CR128","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.3389\/fphar.2019.01302","volume":"10","author":"M-F Ho","year":"2019","unstructured":"Ho M-F et al (2019) Ketamine and active ketamine metabolites regulate STAT3 and the type I interferon pathway in human microglia: molecular mechanisms linked to the antidepressant effects of ketamine. Front Pharmacol 10:1302","journal-title":"Front Pharmacol"},{"issue":"1","key":"4613_CR129","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/s41398-021-01312-y","volume":"11","author":"X-Q Wang","year":"2021","unstructured":"Wang X-Q et al (2021) PTEN in prefrontal cortex is essential in regulating depression-like behaviors in mice. Transl Psychiatry 11(1):185","journal-title":"Transl Psychiatry"},{"issue":"3","key":"4613_CR130","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nn.4225","volume":"19","author":"S Knafo","year":"2016","unstructured":"Knafo S et al (2016) PTEN recruitment controls synaptic and cognitive function in Alzheimer\u2019s models. Nat Neurosci 19(3):443\u2013453","journal-title":"Nat Neurosci"},{"issue":"2","key":"4613_CR131","doi-asserted-by":"crossref","first-page":"H283","DOI":"10.1152\/ajpheart.00813.2016","volume":"313","author":"Y Xu","year":"2017","unstructured":"Xu Y et al (2017) A novel, de novo mutation in the PRKAG2 gene: infantile-onset phenotype and the signaling pathway involved. Am J Physiol Heart Circ Physiol 313(2):H283\u2013H292","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1","key":"4613_CR132","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1210\/en.2014-1042","volume":"156","author":"LJ McCulloch","year":"2015","unstructured":"McCulloch LJ et al (2015) COL6A3 is regulated by leptin in human adipose tissue and reduced in obesity. Endocrinology 156(1):134\u2013146","journal-title":"Endocrinology"},{"issue":"20","key":"4613_CR133","doi-asserted-by":"crossref","first-page":"8845","DOI":"10.18632\/aging.102300","volume":"11","author":"R Long","year":"2019","unstructured":"Long R et al (2019) COL6A6 interacted with P4HA3 to suppress the growth and metastasis of pituitary adenoma via blocking PI3K-Akt pathway. Aging (Albany NY) 11(20):8845","journal-title":"Aging (Albany NY)"},{"issue":"3","key":"4613_CR134","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/00007890-199908150-00010","volume":"68","author":"Y Hoshida","year":"1999","unstructured":"Hoshida Y et al (1999) Renal neoplasias in patients receiving dialysis and renal transplantation: clinico-pathological features and p53 gene mutations. Transplantation 68(3):385\u2013390","journal-title":"Transplantation"},{"key":"4613_CR135","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.2147\/NDT.S54277","volume":"10","author":"LJ Wang","year":"2014","unstructured":"Wang LJ, Chen CK, Hsu HJ, Wu IW, Sun CY, Lee CC (2014) Depression, 5HTTLPR and BDNF Val66Met polymorphisms, and plasma BDNF levels in hemodialysis patients with chronic renal failure. Neuropsychiatric Disease and Treatment 10:1235\u20131241. https:\/\/doi.org\/10.2147\/NDT.S54277","journal-title":"Neuropsychiatric Disease and Treatment"},{"issue":"1","key":"4613_CR136","doi-asserted-by":"crossref","first-page":"e009790","DOI":"10.1136\/bmjopen-2015-009790","volume":"6","author":"D Kim","year":"2016","unstructured":"Kim D et al (2016) Psychological factors and DNA methylation of genes related to immune\/inflammatory system markers: the VA normative aging study. BMJ Open 6(1):e009790","journal-title":"BMJ Open"},{"issue":"3","key":"4613_CR137","doi-asserted-by":"crossref","first-page":"395","DOI":"10.31887\/DCNS.2014.16.3\/amenke","volume":"16","author":"A Menke","year":"2014","unstructured":"Menke A, Binder EB (2014) Epigenetic alterations in depression and antidepressant treatment. Dialogues Clin Neurosci 16(3):395\u2013404","journal-title":"Dialogues Clin Neurosci"},{"issue":"5","key":"4613_CR138","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1177\/1073858415608147","volume":"22","author":"EJ Nestler","year":"2016","unstructured":"Nestler EJ et al (2016) Epigenetic basis of mental illness. Neuroscientist 22(5):447\u2013463","journal-title":"Neuroscientist"},{"key":"4613_CR139","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2045-5380-2-1","volume":"2","author":"AM El-Sayed","year":"2012","unstructured":"El-Sayed AM et al (2012) Epigenetic modifications associated with suicide and common mood and anxiety disorders: a systematic review of the literature. Biol Mood Anxiety Disord 2:1\u201314","journal-title":"Biol Mood Anxiety Disord"},{"issue":"6","key":"4613_CR140","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1097\/YCO.0b013e32833d16c1","volume":"23","author":"M Schroeder","year":"2010","unstructured":"Schroeder M et al (2010) Epigenetics and depression: current challenges and new therapeutic options. Curr Opin Psychiatry 23(6):588\u2013592","journal-title":"Curr Opin Psychiatry"},{"issue":"3","key":"4613_CR141","doi-asserted-by":"crossref","first-page":"463","DOI":"10.21608\/asmj.2022.270146","volume":"73","author":"W-F Bichari","year":"2022","unstructured":"Bichari W-F, Rakha NM (2022) Assessment of nutritional state in prevalent hemodialysis patients and its impact on quality of life. Ain Shams Med J 73(3):463\u2013478","journal-title":"Ain Shams Med J"},{"issue":"5","key":"4613_CR142","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/nrn2132","volume":"8","author":"N Tsankova","year":"2007","unstructured":"Tsankova N et al (2007) Epigenetic regulation in psychiatric disorders. Nat Rev Neurosci 8(5):355\u2013367","journal-title":"Nat Rev Neurosci"},{"key":"4613_CR143","unstructured":"Strack I (2021) The Effect of Dietary Fiber on Epigenetic Regulation of Gene Expression in Hemodialysis Patients (Order No. 28323691). Available from ProQuest Dissertations & Theses Global. (2557831740). http:\/\/cyber.usask.ca\/login?url=https:\/\/www.proquest.com\/dissertations-theses\/effect-dietary-fiber-on-epigenetic-regulation\/docview\/2557831740\/se-2"},{"issue":"18","key":"4613_CR144","doi-asserted-by":"crossref","first-page":"5477","DOI":"10.3390\/jcm11185477","volume":"11","author":"MK \u015awiderska","year":"2022","unstructured":"\u015awiderska MK et al (2022) Energy homeostasis gene nucleotide variants and survival of hemodialysis patients\u2014a genetic cohort study. J Clin Med 11(18):5477","journal-title":"J Clin Med"},{"issue":"1","key":"4613_CR145","first-page":"2180373","volume":"2018","author":"S Mihai","year":"2018","unstructured":"Mihai S et al (2018) Inflammation-related mechanisms in chronic kidney disease prediction, progression, and outcome. J Immunol Res 2018(1):2180373","journal-title":"J Immunol Res"},{"issue":"12","key":"4613_CR146","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1038\/sj.ki.5001865","volume":"70","author":"B Friedrich","year":"2006","unstructured":"Friedrich B et al (2006) Acute effects of hemodialysis on cytokine transcription profiles: evidence for C-reactive protein-dependency of mediator induction. Kidney Int 70(12):2124\u20132130","journal-title":"Kidney Int"},{"key":"4613_CR147","doi-asserted-by":"crossref","first-page":"74743","DOI":"10.3389\/fphar.2013.00159","volume":"4","author":"A Gardet","year":"2013","unstructured":"Gardet A, Zheng TS, Viney JL (2013) Genetic architecture of human fibrotic diseases: disease risk and disease progression. Front Pharmacol 4:74743","journal-title":"Front Pharmacol"},{"issue":"3","key":"4613_CR148","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1042\/bj3420481","volume":"342","author":"Y Morel","year":"1999","unstructured":"Morel Y, Barouki R (1999) Repression of gene expression by oxidative stress. Biochem J 342(3):481\u2013496","journal-title":"Biochem J"},{"key":"4613_CR149","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s003350010230","volume":"12","author":"X Li","year":"2001","unstructured":"Li X et al (2001) Analysis of gene expression in the wound repair\/regeneration process. Mamm Genome 12:52\u201359","journal-title":"Mamm Genome"},{"issue":"1","key":"4613_CR150","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1186\/s12967-023-04356-4","volume":"21","author":"S Shen","year":"2023","unstructured":"Shen S et al (2023) Elucidating shared biomarkers and pathways in kidney stones and diabetes: insights into novel therapeutic targets and the role of resveratrol. J Transl Med 21(1):491","journal-title":"J Transl Med"},{"issue":"1","key":"4613_CR151","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1186\/s12882-022-02922-4","volume":"23","author":"R Zwiech","year":"2022","unstructured":"Zwiech R et al (2022) A potential link between AQP3 and SLC14A1 gene expression level and clinical parameters of maintenance hemodialysis patients. BMC Nephrol 23(1):297","journal-title":"BMC Nephrol"},{"issue":"1","key":"4613_CR152","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/jcsm.12129","volume":"8","author":"D Verzola","year":"2017","unstructured":"Verzola D et al (2017) Toll-like receptor 4 signalling mediates inflammation in skeletal muscle of patients with chronic kidney disease. J Cachexia Sarcopenia Muscle 8(1):131\u2013144","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"4","key":"4613_CR153","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1053\/j.ajkd.2006.05.032","volume":"48","author":"VO Shah","year":"2006","unstructured":"Shah VO et al (2006) Hemodialysis modulates gene expression profile in skeletal muscle. Am J Kidney Dis 48(4):616\u2013628","journal-title":"Am J Kidney Dis"},{"issue":"10","key":"4613_CR154","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.3390\/toxins2102340","volume":"2","author":"N Schupp","year":"2010","unstructured":"Schupp N, Heidland A, Stopper H (2010) Genomic damage in endstage renal disease\u2014contribution of uremic toxins. Toxins 2(10):2340\u20132358","journal-title":"Toxins"},{"issue":"6","key":"4613_CR155","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1053\/j.ajkd.2013.12.004","volume":"63","author":"I Nistor","year":"2014","unstructured":"Nistor I et al (2014) Convective versus diffusive dialysis therapies for chronic kidney failure: an updated systematic review of randomized controlled trials. Am J Kidney Dis 63(6):954\u2013967","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"4613_CR156","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1515\/CCLM.2007.266","volume":"45","author":"Simonetta Palleschi","year":"2007","unstructured":"Palleschi S, Angelis De, Sandro D, Loretta R, Barbara P, Vincenza S, Giancarlo S, Giorgio R (2007) Reliability of oxidative stress biomarkers in hemodialysis patients: a comparative study. Clin Chemi Labor Med (CCLM) 45(9):1211\u20131218. https:\/\/doi.org\/10.1515\/CCLM.2007.266","journal-title":"Clinical Chemistry and Laboratory Medicine (CCLM)"},{"issue":"1","key":"4613_CR157","doi-asserted-by":"crossref","first-page":"10708","DOI":"10.1038\/s41598-019-47065-z","volume":"9","author":"L-M Yeh","year":"2019","unstructured":"Yeh L-M, Chiu S-H, Lai P-C (2019) The impact of vascular access types on hemodialysis patient long-term survival. Sci Rep 9(1):10708","journal-title":"Sci Rep"},{"issue":"1","key":"4613_CR158","first-page":"19","volume":"17","author":"Di Iorio","year":"2004","unstructured":"Iorio Di, Biagio R et al (2004) Vascular access for hemodialysis: the impact on morbidity and mortality. J Nephrol 17(1):19\u201325","journal-title":"J Nephrol"},{"issue":"3","key":"4613_CR159","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/ki.1993.102","volume":"43","author":"R Schindler","year":"1993","unstructured":"Schindler R et al (1993) Gene expression of interleukin-1\u03b2 during hemodialysis. Kidney Int 43(3):712\u2013721","journal-title":"Kidney Int"},{"key":"4613_CR160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1755-8794-6-17","volume":"6","author":"G Zaza","year":"2013","unstructured":"Zaza G et al (2013) A specific immune transcriptomic profile discriminates chronic kidney disease patients in predialysis from hemodialyzed patients. BMC Med Genomics 6:1\u201311","journal-title":"BMC Med Genomics"},{"issue":"3","key":"4613_CR161","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1142\/S0192415X06003916","volume":"34","author":"C-S Chen","year":"2006","unstructured":"Chen C-S et al (2006) Differential gene expression in hemodialysis patients with\" cold\" Zheng. Am J Chin Med 34(3):377\u2013385","journal-title":"Am J Chin Med"},{"issue":"12","key":"4613_CR162","first-page":"4059","volume":"93","author":"R Singal","year":"1999","unstructured":"Singal R, Ginder GD (1999) DNA methylation. Blood J Am Soc Hematol 93(12):4059\u20134070","journal-title":"Blood J Am Soc Hematol"},{"issue":"1","key":"4613_CR163","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/npp.2012.112","volume":"38","author":"LD Moore","year":"2013","unstructured":"Moore LD, Le T, Fan G (2013) DNA methylation and its basic function. Neuropsychopharmacology 38(1):23\u201338","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"4613_CR164","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1080\/21655979.2021.2014387","volume":"13","author":"Nasrullah","year":"2022","unstructured":"Nasrullah et al (2022) DNA methylation across the tree of life, from micro to macro-organism. Bioengineered 13(1):1666\u20131685","journal-title":"Bioengineered"},{"key":"4613_CR165","first-page":"429871","volume":"9","author":"S Kumar","year":"2018","unstructured":"Kumar S, Chinnusamy V, Mohapatra T (2018) Epigenetics of modified DNA bases: 5-methylcytosine and beyond. Front Genet 9:429871","journal-title":"Front Genet"},{"issue":"10","key":"4613_CR166","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1101\/gad.2037511","volume":"25","author":"AM Deaton","year":"2011","unstructured":"Deaton AM, Bird A (2011) CpG islands and the regulation of transcription. Genes Dev 25(10):1010\u20131022","journal-title":"Genes Dev"},{"issue":"8","key":"4613_CR167","doi-asserted-by":"crossref","first-page":"194567","DOI":"10.1016\/j.bbagrm.2020.194567","volume":"1863","author":"AL Hughes","year":"2020","unstructured":"Hughes AL, Kelley JR, Klose RJ (2020) Understanding the interplay between CpG island-associated gene promoters and H3K4 methylation. Biochimica et Biophysica Acta (BBA) Gene Regul Mech 1863(8):194567","journal-title":"Biochimica et Biophysica Acta (BBA) Gene Regul Mech"},{"issue":"6","key":"4613_CR168","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1177\/1947601910393957","volume":"2","author":"B Jin","year":"2011","unstructured":"Jin B, Li Y, Robertson KD (2011) DNA methylation: superior or subordinate in the epigenetic hierarchy? Genes Cancer 2(6):607\u2013617","journal-title":"Genes Cancer"},{"key":"4613_CR169","doi-asserted-by":"publisher","unstructured":"Miller JL, Grant PA (2013) The Role of DNA Methylation and Histone Modifications in Transcriptional Regulation in Humans. In: Kundu T (eds) Epigenetics: Development and Disease. Subcellular Biochemistry, vol 61. Springer, Dordrecht. https:\/\/doi.org\/10.1007\/978-94-007-4525-4_13","DOI":"10.1007\/978-94-007-4525-4_13"},{"issue":"4","key":"4613_CR170","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1515\/BC.2008.048","volume":"389","author":"KA Gelato","year":"2008","unstructured":"Gelato KA, Fischle W (2008) Role of histone modifications in defining chromatin structure and function.  Biol Chem 389(4):353\u2013363. https:\/\/doi.org\/10.1515\/BC.2008.048","journal-title":"Biol Chem"},{"issue":"2","key":"4613_CR171","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3109\/10409238609083735","volume":"20","author":"RS Wu","year":"1986","unstructured":"Wu RS et al (1986) Histones and their modification. Crit Rev Biochem 20(2):201\u2013263","journal-title":"Crit Rev Biochem"},{"key":"4613_CR172","doi-asserted-by":"publisher","unstructured":"Zhang Y et al. (2021) Overview of Histone Modification. In: Fang, D., Han, J. (eds) Histone Mutations and Cancer. Advances in Experimental Medicine and Biology, vol 1283. Springer, Singapore. https:\/\/doi.org\/10.1007\/978-981-15-8104-5_1","DOI":"10.1007\/978-981-15-8104-5_1"},{"issue":"6","key":"4613_CR173","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1021\/cr500350x","volume":"115","author":"GD Bowman","year":"2014","unstructured":"Bowman GD, Poirier MG (2014) Post-translational modifications of histones that influence nucleosome dynamics. Chem Rev 115(6):2274\u20132295","journal-title":"Chem Rev"},{"key":"4613_CR174","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1146\/annurev.biochem.75.103004.142422","volume":"75","author":"A Shilatifard","year":"2006","unstructured":"Shilatifard A (2006) Chromatin modifications by methylation and ubiquitination: implications in the regulation of gene expression. Annu Rev Biochem 75:243\u2013269","journal-title":"Annu Rev Biochem"},{"issue":"1","key":"4613_CR175","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13578-022-00821-7","volume":"12","author":"P Zhao","year":"2022","unstructured":"Zhao P, Malik S (2022) The phosphorylation to acetylation\/methylation cascade in transcriptional regulation: how kinases regulate transcriptional activities of DNA\/histone-modifying enzymes. Cell Biosci 12(1):83","journal-title":"Cell Biosci"},{"key":"4613_CR176","doi-asserted-by":"crossref","unstructured":"Sonia Albini, Vlada Zakharova, Slimane Ait-Si-Ali, Chapter 3 - Histone Modifications, Editor(s): Daniela Palacios, In Translational Epigenetics, Epigenetics and Regeneration, Academic Press, Volume 11, 2019, Pages 47-72, ISSN 25425358, ISBN 9780128148792, https:\/\/doi.org\/10.1016\/B978-0-12-814879-2.00003-0","DOI":"10.1016\/B978-0-12-814879-2.00003-0"},{"issue":"21","key":"4613_CR177","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1002\/anie.200461346","volume":"44","author":"M Biel","year":"2005","unstructured":"Biel M, Wascholowski V, Giannis A (2005) Epigenetics\u2014an epicenter of gene regulation: histones and histone-modifying enzymes. Angew Chem Int Ed 44(21):3186\u20133216","journal-title":"Angew Chem Int Ed"},{"issue":"10","key":"4613_CR178","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.4161\/epi.21975","volume":"7","author":"D Rossetto","year":"2012","unstructured":"Rossetto D, Avvakumov N, C\u00f4t\u00e9 J (2012) Histone phosphorylation: a chromatin modification involved in diverse nuclear events. Epigenetics 7(10):1098\u20131108","journal-title":"Epigenetics"},{"issue":"1","key":"4613_CR179","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-1119(99)00405-9","volume":"240","author":"VA Spencer","year":"1999","unstructured":"Spencer VA, Davie JR (1999) Role of covalent modifications of histones in regulating gene expression. Gene 240(1):1\u201312","journal-title":"Gene"},{"issue":"1","key":"4613_CR180","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.bbagrm.2008.07.009","volume":"1789","author":"R Marmorstein","year":"2009","unstructured":"Marmorstein R, Trievel RC (2009) Histone modifying enzymes: structures, mechanisms, and specificities. Biochimica et Biophysica Acta (BBA) Gene Regulatory Mechanisms 1789(1):58\u201368","journal-title":"Biochimica et Biophysica Acta (BBA) Gene Regulatory Mechanisms"},{"issue":"4","key":"4613_CR181","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1080\/21541264.2017.1311829","volume":"8","author":"E Rosonina","year":"2017","unstructured":"Rosonina E et al (2017) Regulation of transcription factors by sumoylation. Transcription 8(4):220\u2013231","journal-title":"Transcription"},{"issue":"1","key":"4613_CR182","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/cbf.3079","volume":"33","author":"B Santosh","year":"2015","unstructured":"Santosh B, Varshney A, Yadava PK (2015) Non-coding RNAs: biological functions and applications. Cell Biochem Funct 33(1):14\u201322","journal-title":"Cell Biochem Funct"},{"key":"4613_CR183","doi-asserted-by":"crossref","first-page":"641351","DOI":"10.3389\/fpls.2021.641351","volume":"12","author":"Yi Ren","year":"2021","unstructured":"Ren Yi et al (2021) Coding of non-coding RNA: insights into the regulatory functions of pri-microRNA-encoded peptides in plants. Front Plant Sci 12:641351","journal-title":"Front Plant Sci"},{"issue":"7","key":"4613_CR184","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.3390\/cells9071574","volume":"9","author":"U Ala","year":"2020","unstructured":"Ala U (2020) Competing endogenous RNAs, non-coding RNAs and diseases: an intertwined story. Cells 9(7):1574","journal-title":"Cells"},{"issue":"7","key":"4613_CR185","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.4049\/jimmunol.1500756","volume":"195","author":"J Schwerk","year":"2015","unstructured":"Schwerk J, Savan R (2015) Translating the untranslated region. J Immunol 195(7):2963\u20132971","journal-title":"J Immunol"},{"key":"4613_CR186","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1042\/bse0540029","volume":"54","author":"T Dalmay","year":"2013","unstructured":"Dalmay T (2013) Mechanism of miRNA-mediated repression of mRNA translation. Essays Biochem 54:29\u201338","journal-title":"Essays Biochem"},{"key":"4613_CR187","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00018-018-2940-7","volume":"76","author":"M Pu","year":"2019","unstructured":"Pu M et al (2019) Regulatory network of miRNA on its target: coordination between transcriptional and post-transcriptional regulation of gene expression. Cell Mol Life Sci 76:441\u2013451","journal-title":"Cell Mol Life Sci"},{"key":"4613_CR188","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cbpa.2019.01.024","volume":"51","author":"Q Yao","year":"2019","unstructured":"Yao Q, Chen Y, Zhou X (2019) The roles of microRNAs in epigenetic regulation. Curr Opin Chem Biol 51:11\u201317","journal-title":"Curr Opin Chem Biol"},{"key":"4613_CR189","doi-asserted-by":"publisher","unstructured":"Clark J, RagerJE (2020) Chapter 1 - epigenetics: an overview of CpG methylation, chromatin remodeling, and regulatory\/noncoding RNAs, Editor(s): Rebecca C. Fry, In Translational Epigenetics, Environmental Epigenetics in Toxicology and Public Health, Academic Press, Volume 22:3\u201332, ISSN 25425358, ISBN 9780128199688, https:\/\/doi.org\/10.1016\/B978-0-12-819968-8.00001-9.","DOI":"10.1016\/B978-0-12-819968-8.00001-9"},{"issue":"10","key":"4613_CR190","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.3390\/cancers12102922","volume":"12","author":"KMT Arif","year":"2020","unstructured":"Arif KMT et al (2020) Regulatory mechanisms of epigenetic miRNA relationships in human cancer and potential as therapeutic targets. Cancers 12(10):2922","journal-title":"Cancers"},{"issue":"10","key":"4613_CR191","doi-asserted-by":"crossref","first-page":"5801","DOI":"10.3390\/ijms23105801","volume":"23","author":"IV Bure","year":"2022","unstructured":"Bure IV, Nemtsova MV, Kuznetsova EB (2022) Histone modifications and non-coding RNAs: mutual epigenetic regulation and role in pathogenesis. Int J Mol Sci 23(10):5801","journal-title":"Int J Mol Sci"},{"issue":"1","key":"4613_CR192","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.biocel.2008.09.005","volume":"41","author":"S Guil","year":"2009","unstructured":"Guil S, Esteller M (2009) DNA methylomes, histone codes and miRNAs: tying it all together. Int J Biochem Cell Biol 41(1):87\u201395","journal-title":"Int J Biochem Cell Biol"},{"issue":"11","key":"4613_CR193","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.3390\/genes11111336","volume":"11","author":"J Loaeza-Loaeza","year":"2020","unstructured":"Loaeza-Loaeza J, Beltran AS, Hern\u00e1ndez-Sotelo D (2020) DNMTs and impact of CpG content, transcription factors, consensus motifs, lncRNAs, and histone marks on DNA methylation. Genes 11(11):1336","journal-title":"Genes"},{"issue":"9","key":"4613_CR194","doi-asserted-by":"crossref","first-page":"882","DOI":"10.3748\/wjg.v18.i9.882","volume":"18","author":"X-Q Li","year":"2012","unstructured":"Li X-Q, Guo Y-Y, De W (2012) DNA methylation and microRNAs in cancer. World J Gastroenterol WJG 18(9):882","journal-title":"World J Gastroenterol WJG"},{"issue":"10","key":"4613_CR195","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/nep.12521","volume":"20","author":"R Rodr\u00edguez-Romo","year":"2015","unstructured":"Rodr\u00edguez-Romo R et al (2015) Epigenetic regulation in the acute kidney injury to chronic kidney disease transition. Nephrology 20(10):736\u2013743","journal-title":"Nephrology"},{"key":"4613_CR196","doi-asserted-by":"crossref","first-page":"649587","DOI":"10.3389\/fphys.2021.649587","volume":"12","author":"B-Y Shao","year":"2021","unstructured":"Shao B-Y et al (2021) Epigenetics and inflammation in diabetic nephropathy. Front Physiol 12:649587","journal-title":"Front Physiol"},{"issue":"1","key":"4613_CR197","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s13148-021-01079-5","volume":"13","author":"W Zheng","year":"2021","unstructured":"Zheng W, Guo J, Liu Z-S (2021) Effects of metabolic memory on inflammation and fibrosis associated with diabetic kidney disease: an epigenetic perspective. Clin Epigenetics 13(1):87","journal-title":"Clin Epigenetics"},{"issue":"6","key":"4613_CR198","doi-asserted-by":"crossref","first-page":"F1329","DOI":"10.1152\/ajprenal.00487.2016","volume":"311","author":"O Ruiz-Andres","year":"2016","unstructured":"Ruiz-Andres O et al (2016) Downregulation of kidney protective factors by inflammation: role of transcription factors and epigenetic mechanisms. Am J Physiol Renal Physiol 311(6):F1329\u2013F1340","journal-title":"Am J Physiol Renal Physiol"},{"issue":"1","key":"4613_CR199","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/s41598-021-04321-5","volume":"12","author":"A Witasp","year":"2022","unstructured":"Witasp A et al (2022) Longitudinal genome-wide DNA methylation changes in response to kidney failure replacement therapy. Sci Rep 12(1):470","journal-title":"Sci Rep"},{"issue":"1","key":"4613_CR200","first-page":"2931049","volume":"2018","author":"JL Morgado-Pascual","year":"2018","unstructured":"Morgado-Pascual JL et al (2018) Epigenetic modification mechanisms involved in inflammation and fibrosis in renal pathology. Mediat Inflamm 2018(1):2931049","journal-title":"Mediat Inflamm"},{"key":"4613_CR201","doi-asserted-by":"crossref","first-page":"931493","DOI":"10.3389\/fcell.2022.931493","volume":"10","author":"SY Tan","year":"2022","unstructured":"Tan SY, Xuan JZ, Tee W-W (2022) Epigenetic regulation of inflammatory signaling and inflammation-induced cancer. Front Cell Dev Biol 10:931493","journal-title":"Front Cell Dev Biol"},{"issue":"26","key":"4613_CR202","doi-asserted-by":"crossref","first-page":"34121","DOI":"10.1007\/s11356-021-14109-9","volume":"28","author":"T Donia","year":"2021","unstructured":"Donia T, Khamis A (2021) Management of oxidative stress and inflammation in cardiovascular diseases: mechanisms and challenges. Environ Sci Pollut Res 28(26):34121\u201334153","journal-title":"Environ Sci Pollut Res"},{"issue":"1","key":"4613_CR203","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1159\/000339437","volume":"2","author":"S Kato","year":"2012","unstructured":"Kato S et al (2012) DNA hypermethylation and inflammatory markers in incident Japanese dialysis patients. Nephron extra 2(1):159\u2013168","journal-title":"Nephron extra"},{"key":"4613_CR204","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ejphar.2017.12.016","volume":"820","author":"W Lv","year":"2018","unstructured":"Lv W et al (2018) Inflammation and renal fibrosis: recent developments on key signaling molecules as potential therapeutic targets. Eur J Pharmacol 820:65\u201376","journal-title":"Eur J Pharmacol"},{"key":"4613_CR205","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.mrrev.2017.09.003","volume":"780","author":"F Gong","year":"2019","unstructured":"Gong F, Miller KM (2019) Histone methylation and the DNA damage response. Mutat Res Revin Mutat Res 780:37\u201347","journal-title":"Mutat Res Revin Mutat Res"},{"key":"4613_CR206","doi-asserted-by":"crossref","first-page":"420154","DOI":"10.3389\/fimmu.2018.02542","volume":"9","author":"E Platanitis","year":"2018","unstructured":"Platanitis E, Decker T (2018) Regulatory networks involving STATs, IRFs, and NF\u03baB in inflammation. Front Immunol 9:420154","journal-title":"Front Immunol"},{"issue":"10","key":"4613_CR207","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/nri2634","volume":"9","author":"R Medzhitov","year":"2009","unstructured":"Medzhitov R, Horng T (2009) Transcriptional control of the inflammatory response. Nat Rev Immunol 9(10):692\u2013703","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"4613_CR208","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/cmi.2016.58","volume":"13","author":"J Liu","year":"2016","unstructured":"Liu J, Cao X (2016) Cellular and molecular regulation of innate inflammatory responses. Cell Mol Immunol 13(6):711\u2013721","journal-title":"Cell Mol Immunol"},{"issue":"1","key":"4613_CR209","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1177\/0022034510378683","volume":"90","author":"D Bayarsaihan","year":"2011","unstructured":"Bayarsaihan D (2011) Epigenetic mechanisms in inflammation. J Dent Res 90(1):9\u201317","journal-title":"J Dent Res"},{"issue":"9","key":"4613_CR210","doi-asserted-by":"crossref","first-page":"6495","DOI":"10.1002\/jcp.26497","volume":"233","author":"MG Daskalaki","year":"2018","unstructured":"Daskalaki MG, Tsatsanis C, Kampranis SC (2018) Histone methylation and acetylation in macrophages as a mechanism for regulation of inflammatory responses. J Cell Physiol 233(9):6495\u20136507","journal-title":"J Cell Physiol"},{"issue":"1","key":"4613_CR211","doi-asserted-by":"crossref","first-page":"201703","DOI":"10.1155\/2015\/201703","volume":"2015","author":"R Yasmin","year":"2015","unstructured":"Yasmin R et al (2015) Epigenetic regulation of inflammatory cytokines and associated genes in human malignancies. Mediat Inflamm 2015(1):201703","journal-title":"Mediat Inflamm"},{"key":"4613_CR212","doi-asserted-by":"crossref","first-page":"756458","DOI":"10.3389\/fcell.2021.756458","volume":"9","author":"D Das","year":"2021","unstructured":"Das D, Karthik N, Taneja R (2021) Crosstalk between inflammatory signaling and methylation in cancer. Front Cell Dev Biol 9:756458","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"4613_CR213","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.biocel.2008.08.023","volume":"41","author":"L B\u00e4ckdahl","year":"2009","unstructured":"B\u00e4ckdahl L, Bushell A, Beck S (2009) Inflammatory signalling as mediator of epigenetic modulation in tissue-specific chronic inflammation. Int J Biochem Cell Biol 41(1):176\u2013184","journal-title":"Int J Biochem Cell Biol"},{"issue":"5","key":"4613_CR214","doi-asserted-by":"crossref","first-page":"553","DOI":"10.2217\/epi.13.43","volume":"5","author":"M Ehrlich","year":"2013","unstructured":"Ehrlich M, Lacey M (2013) DNA methylation and differentiation: silencing, upregulation and modulation of gene expression. Epigenomics 5(5):553\u2013568","journal-title":"Epigenomics"},{"key":"4613_CR215","doi-asserted-by":"crossref","first-page":"466419","DOI":"10.3389\/fimmu.2019.01525","volume":"10","author":"Surace","year":"2019","unstructured":"Surace, Andrea AE, Hedrich CM (2019) The role of epigenetics in autoimmune\/inflammatory disease. Front Immunol 10:466419","journal-title":"Front Immunol"},{"issue":"10","key":"4613_CR216","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.3109\/0886022X.2012.723280","volume":"34","author":"C-Y Hsu","year":"2012","unstructured":"Hsu C-Y et al (2012) Global DNA methylation not increased in chronic hemodialysis patients: a case\u2013control study. Ren Fail 34(10):1195\u20131199","journal-title":"Ren Fail"},{"key":"4613_CR217","doi-asserted-by":"publisher","unstructured":"Shanmugam MK, Sethi G (2013) Role of Epigenetics in Inflammation-Associated Diseases. In: Kundu T (eds) Epigenetics: Development and Disease. Subcellular Biochemistry, vol 61. Springer, Dordrecht. https:\/\/doi.org\/10.1007\/978-94-007-4525-4_27","DOI":"10.1007\/978-94-007-4525-4_27"},{"issue":"3","key":"4613_CR218","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/S10059-009-0127-7","volume":"28","author":"KB Falbo","year":"2009","unstructured":"Falbo KB, Shen X (2009) Histone modifications during DNA replication. Mol Cells 28(3):149\u2013154","journal-title":"Mol Cells"},{"issue":"9","key":"4613_CR219","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.tcb.2011.06.001","volume":"21","author":"S Messner","year":"2011","unstructured":"Messner S, Hottiger MO (2011) Histone ADP-ribosylation in DNA repair, replication and transcription. Trends Cell Biol 21(9):534\u2013542","journal-title":"Trends Cell Biol"},{"issue":"1","key":"4613_CR220","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s12038-020-00099-2","volume":"45","author":"S Ramazi","year":"2020","unstructured":"Ramazi S, Allahverdi A, Zahiri J (2020) Evaluation of post-translational modifications in histone proteins: a review on histone modification defects in developmental and neurological disorders. J Biosci 45(1):135","journal-title":"J Biosci"},{"key":"4613_CR221","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/bs.pmbts.2023.01.001","volume":"197","author":"S Acharjee","year":"2023","unstructured":"Acharjee S et al (2023) Mechanisms of DNA methylation and histone modifications. Prog Mol Biol Transl Sci 197:51\u201392","journal-title":"Prog Mol Biol Transl Sci"},{"key":"4613_CR222","doi-asserted-by":"crossref","first-page":"1238706","DOI":"10.3389\/fphar.2023.1238706","volume":"14","author":"Z Liu","year":"2023","unstructured":"Liu Z et al (2023) Functioning and mechanisms of PTMs in renal diseases. Front Pharmacol 14:1238706","journal-title":"Front Pharmacol"},{"key":"4613_CR223","doi-asserted-by":"publisher","first-page":"329","DOI":"10.2147\/DMSO.S288500","volume":"14","author":"HC Lu","year":"2021","unstructured":"Lu HC, Dai WN, He LY (2021) Epigenetic histone modifications in the pathogenesis of diabetic kidney disease. Diabet Metab Syn Obes 14:329\u2013344. https:\/\/doi.org\/10.2147\/DMSO.S288500","journal-title":"Diabetes, Metabolic Syndrome and Obesity"},{"key":"4613_CR224","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/bs.acc.2020.09.005","volume":"104","author":"H Ding","year":"2021","unstructured":"Ding H et al (2021) Epigenetics in kidney diseases. Adv Clin Chem 104:233\u2013297","journal-title":"Adv Clin Chem"},{"issue":"1","key":"4613_CR225","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s00109-021-02141-8","volume":"100","author":"L Zhang","year":"2022","unstructured":"Zhang L, Cao W (2022) Histone deacetylase 3 (HDAC3) as an important epigenetic regulator of kidney diseases. J Mol Med 100(1):43\u201351","journal-title":"J Mol Med"},{"key":"4613_CR226","doi-asserted-by":"crossref","first-page":"760308","DOI":"10.3389\/fphar.2022.760308","volume":"13","author":"F Shen","year":"2022","unstructured":"Shen F, Zhuang S (2022) Histone acetylation and modifiers in renal fibrosis. Front Pharmacol 13:760308","journal-title":"Front Pharmacol"},{"issue":"11","key":"4613_CR227","doi-asserted-by":"crossref","first-page":"4113","DOI":"10.3390\/ijms21114113","volume":"21","author":"JM Martinez-Moreno","year":"2020","unstructured":"Martinez-Moreno JM et al (2020) Epigenetic modifiers as potential therapeutic targets in diabetic kidney disease. Int J Mol Sci 21(11):4113","journal-title":"Int J Mol Sci"},{"issue":"1","key":"4613_CR228","first-page":"7242384","volume":"2017","author":"J Sun","year":"2017","unstructured":"Sun J et al (2017) Role of epigenetic histone modifications in diabetic kidney disease involving renal fibrosis. J Diabetes Res 2017(1):7242384","journal-title":"J Diabetes Res"},{"issue":"6","key":"4613_CR229","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1159\/000517073","volume":"145","author":"Z Li","year":"2021","unstructured":"Li Z, Li N (2021) Epigenetic modification drives acute kidney injury-to-chronic kidney disease progression. Nephron 145(6):737\u2013747","journal-title":"Nephron"},{"issue":"2","key":"4613_CR230","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3390\/ph15020123","volume":"15","author":"F Tanemoto","year":"2022","unstructured":"Tanemoto F, Mimura I (2022) Therapies targeting epigenetic alterations in acute kidney injury-to-chronic kidney disease transition. Pharmaceuticals 15(2):123","journal-title":"Pharmaceuticals"},{"issue":"4","key":"4613_CR231","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/s41581-018-0103-6","volume":"15","author":"C Guo","year":"2019","unstructured":"Guo C et al (2019) Epigenetic regulation in AKI and kidney repair: mechanisms and therapeutic implications. Nat Rev Nephrol 15(4):220\u2013239","journal-title":"Nat Rev Nephrol"},{"key":"4613_CR232","doi-asserted-by":"crossref","first-page":"861498","DOI":"10.3389\/fimmu.2022.861498","volume":"13","author":"X Xiang","year":"2022","unstructured":"Xiang X et al (2022) Epigenetic regulation in kidney transplantation. Front Immunol 13:861498","journal-title":"Front Immunol"},{"issue":"7","key":"4613_CR233","doi-asserted-by":"crossref","first-page":"694","DOI":"10.4161\/epi.25201","volume":"8","author":"B Su\u00e1rez-\u00c1lvarez","year":"2013","unstructured":"Su\u00e1rez-\u00c1lvarez B et al (2013) Epigenetic modulation of the immune function: a potential target for tolerance. Epigenetics 8(7):694\u2013702","journal-title":"Epigenetics"},{"issue":"3","key":"4613_CR234","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/icb.2008.106","volume":"87","author":"L Wang","year":"2009","unstructured":"Wang L, Tao R, Hancock WW (2009) Using histone deacetylase inhibitors to enhance Foxp3+ regulatory T-cell function and induce allograft tolerance. Immunol Cell Biol 87(3):195\u2013202","journal-title":"Immunol Cell Biol"},{"issue":"5","key":"4613_CR235","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/ijc.23325","volume":"122","author":"N Yang","year":"2008","unstructured":"Yang N, Coukos G, Zhang L (2008) MicroRNA epigenetic alterations in human cancer: one step forward in diagnosis and treatment. Int J Cancer 122(5):963\u2013968","journal-title":"Int J Cancer"},{"key":"4613_CR236","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/bs.acr.2017.06.003","volume":"135","author":"C Moutinho","year":"2017","unstructured":"Moutinho C, Esteller M (2017) MicroRNAs and epigenetics. Adv Cancer Res 135:189\u2013220","journal-title":"Adv Cancer Res"},{"issue":"25","key":"4613_CR237","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.2217\/fon-2017-0363","volume":"13","author":"V Holubekova","year":"2017","unstructured":"Holubekova V et al (2017) Epigenetic regulation by DNA methylation and miRNA molecules in cancer. Future Oncol 13(25):2217\u20132222","journal-title":"Future Oncol"},{"issue":"5","key":"4613_CR238","doi-asserted-by":"crossref","first-page":"6080","DOI":"10.3390\/molecules19056080","volume":"19","author":"JR Chevillet","year":"2014","unstructured":"Chevillet JR et al (2014) Issues and prospects of microRNA-based biomarkers in blood and other body fluids. Molecules 19(5):6080\u20136105","journal-title":"Molecules"},{"issue":"2","key":"4613_CR239","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/wrna.1208","volume":"5","author":"H Liang","year":"2014","unstructured":"Liang H et al (2014) The origin, function, and diagnostic potential of extracellular microRNAs in human body fluids. Wiley Interdiscip Rev RNA 5(2):285\u2013300","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"4613_CR240","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1146\/annurev-immunol-020711-075013","volume":"30","author":"RM O'Connell","year":"2012","unstructured":"O\u2019Connell RM, Rao DS, Baltimore D (2012) microRNA regulation of inflammatory responses. Annu Rev Immunol 30:295\u2013312","journal-title":"Annu Rev Immunol"},{"key":"4613_CR241","doi-asserted-by":"crossref","first-page":"337488","DOI":"10.3389\/fimmu.2018.01377","volume":"9","author":"A Tahamtan","year":"2018","unstructured":"Tahamtan A et al (2018) Anti-inflammatory microRNAs and their potential for inflammatory diseases treatment. Front Immunol 9:337488","journal-title":"Front Immunol"},{"issue":"18","key":"4613_CR242","doi-asserted-by":"crossref","first-page":"6738","DOI":"10.3390\/ijms21186738","volume":"21","author":"Y-L Wu","year":"2020","unstructured":"Wu Y-L et al (2020) MicroRNAs as biomarkers and therapeutic targets in inflammation-and ischemia-reperfusion-related acute renal injury. Int J Mol Sci 21(18):6738","journal-title":"Int J Mol Sci"},{"issue":"5","key":"4613_CR243","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/nrneph.2011.26","volume":"7","author":"JM Lorenzen","year":"2011","unstructured":"Lorenzen JM, Haller H, Thum T (2011) MicroRNAs as mediators and therapeutic targets in chronic kidney disease. Nat Rev Nephrol 7(5):286\u2013294","journal-title":"Nat Rev Nephrol"},{"issue":"4","key":"4613_CR244","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.trsl.2011.01.007","volume":"157","author":"R Dai","year":"2011","unstructured":"Dai R, Ansar Ahmed S (2011) MicroRNA, a new paradigm for understanding immunoregulation, inflammation, and autoimmune diseases. Transl Res 157(4):163\u2013179","journal-title":"Transl Res"},{"key":"4613_CR245","doi-asserted-by":"crossref","first-page":"502685","DOI":"10.3389\/fimmu.2019.03081","volume":"10","author":"K Chandan","year":"2020","unstructured":"Chandan K, Gupta M, Sarwat M (2020) Role of host and pathogen-derived microRNAs in immune regulation during infectious and inflammatory diseases. Front Immunol 10:502685","journal-title":"Front Immunol"},{"issue":"24","key":"4613_CR246","doi-asserted-by":"crossref","first-page":"15479","DOI":"10.3390\/ijms232415479","volume":"23","author":"K Das","year":"2022","unstructured":"Das K, Vijaya Mohan Rao L (2022) The role of microRNAs in inflammation. Int J Mol Sci 23(24):15479","journal-title":"Int J Mol Sci"},{"key":"4613_CR247","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.canlet.2018.04.016","volume":"428","author":"H Long","year":"2018","unstructured":"Long H et al (2018) Dysregulation of microRNAs in autoimmune diseases: pathogenesis, biomarkers and potential therapeutic targets. Cancer Lett 428:90\u2013103","journal-title":"Cancer Lett"},{"issue":"12","key":"4613_CR248","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.autrev.2013.07.003","volume":"12","author":"RP Singh","year":"2013","unstructured":"Singh RP et al (2013) The role of miRNA in inflammation and autoimmunity. Autoimmun Rev 12(12):1160\u20131165","journal-title":"Autoimmun Rev"},{"key":"4613_CR249","doi-asserted-by":"publisher","unstructured":"Lee S, Vasudevan S (2013) Post-transcriptional stimulation of gene expression by MicroRNAs. In: Chan E, Fritzler M (eds) Ten Years of Progress in GW\/P Body Research. Advances in Experimental Medicine and Biology, vol 768. Springer, New York, NY. https:\/\/doi.org\/10.1007\/978-1-4614-5107-5_7","DOI":"10.1007\/978-1-4614-5107-5_7"},{"issue":"3","key":"4613_CR250","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1155\/2012\/842764","volume":"33","author":"C-C Szeto","year":"2012","unstructured":"Szeto C-C et al (2012) Micro-RNA expression in the urinary sediment of patients with chronic kidney diseases. Dis Markers 33(3):137\u2013144","journal-title":"Dis Markers"},{"key":"4613_CR251","doi-asserted-by":"crossref","first-page":"154725","DOI":"10.1016\/j.prp.2023.154725","volume":"249","author":"R Mirzaei","year":"2023","unstructured":"Mirzaei R, Karampoor S, Korotkova NL (2023) The emerging role of miRNA-122 in infectious diseases: mechanisms and potential biomarkers. Pathol Res Pract 249:154725","journal-title":"Pathol Res Pract"},{"issue":"1","key":"4613_CR252","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s10020-022-00527-z","volume":"28","author":"A Formosa","year":"2022","unstructured":"Formosa A, Turgeon P, Dos Santos CC (2022) Role of miRNA dysregulation in sepsis. Mol Med 28(1):99","journal-title":"Mol Med"},{"issue":"4","key":"4613_CR253","first-page":"3352","volume":"20","author":"H Li","year":"2020","unstructured":"Li H et al (2020) Changes of miR 155 expression in serum of uremic patients before and after treatment and risk factors analysis. Exp Ther Med 20(4):3352\u20133360","journal-title":"Exp Ther Med"},{"key":"4613_CR254","first-page":"1","volume":"17","author":"P-C Fan","year":"2019","unstructured":"Fan P-C et al (2019) A circulating miRNA signature for early diagnosis of acute kidney injury following acute myocardial infarction. J Transl Med 17:1\u201312","journal-title":"J Transl Med"},{"issue":"5","key":"4613_CR255","doi-asserted-by":"crossref","first-page":"F785","DOI":"10.1152\/ajprenal.00368.2018","volume":"316","author":"IO Sun","year":"2019","unstructured":"Sun IO, Lerman LO (2019) Urinary microRNA in kidney disease: utility and roles. Am J Physiol Renal Physiol 316(5):F785\u2013F793","journal-title":"Am J Physiol Renal Physiol"},{"issue":"15","key":"4613_CR256","doi-asserted-by":"crossref","first-page":"5010","DOI":"10.3390\/jcm12155010","volume":"12","author":"C Kuscu","year":"2023","unstructured":"Kuscu C et al (2023) Circulating microRNA profiles for premature cardiovascular death in patients with kidney failure with replacement therapy. J Clin Med 12(15):5010","journal-title":"J Clin Med"},{"issue":"5","key":"4613_CR257","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.1365-2796.2007.01777.x","volume":"261","author":"P Stenvinkel","year":"2007","unstructured":"Stenvinkel P et al (2007) Impact of inflammation on epigenetic DNA methylation\u2013a novel risk factor for cardiovascular disease? J Intern Med 261(5):488\u2013499","journal-title":"J Intern Med"},{"key":"4613_CR258","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s11033-013-2906-7","volume":"41","author":"M Ghattas","year":"2014","unstructured":"Ghattas M et al (2014) DNA methylation status of the methylenetetrahydrofolate reductase gene promoter in peripheral blood of end-stage renal disease patients. Mol Biol Rep 41:683\u2013688","journal-title":"Mol Biol Rep"},{"issue":"1","key":"4613_CR259","doi-asserted-by":"crossref","first-page":"2214394","DOI":"10.1080\/15592294.2023.2214394","volume":"18","author":"K Sumida","year":"2023","unstructured":"Sumida K et al (2023) Association of DNA methylation signatures with premature ageing and cardiovascular death in patients with end-stage kidney disease: a pilot epigenome-wide association study. Epigenetics 18(1):2214394","journal-title":"Epigenetics"},{"issue":"5","key":"4613_CR260","doi-asserted-by":"crossref","first-page":"623","DOI":"10.4161\/epi.6.5.15335","volume":"6","author":"FF Zhang","year":"2011","unstructured":"Zhang FF et al (2011) Significant differences in global genomic DNA methylation by gender and race\/ethnicity in peripheral blood. Epigenetics 6(5):623\u2013629","journal-title":"Epigenetics"},{"issue":"2","key":"4613_CR261","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/ajt.16183","volume":"21","author":"C Zhu","year":"2021","unstructured":"Zhu C et al (2021) DNA methylation modulates allograft survival and acute rejection after renal transplantation by regulating the mTOR pathway. Am J Transplant 21(2):567\u2013581","journal-title":"Am J Transplant"},{"issue":"suppl_3","key":"4613_CR262","doi-asserted-by":"crossref","first-page":"iii35","DOI":"10.1093\/ndt\/gfy175","volume":"33","author":"G Cobo","year":"2018","unstructured":"Cobo G, Lindholm B, Stenvinkel P (2018) Chronic inflammation in end-stage renal disease and dialysis. Nephrol Dial Transplant 33(suppl_3):iii35\u2013iii40","journal-title":"Nephrol Dial Transplant"},{"issue":"13","key":"4613_CR263","doi-asserted-by":"crossref","first-page":"3759","DOI":"10.3390\/jcm11133759","volume":"11","author":"S Campo","year":"2022","unstructured":"Campo S et al (2022) Immune system dysfunction and inflammation in hemodialysis patients: two sides of the same coin. J Clin Med 11(13):3759","journal-title":"J Clin Med"},{"key":"4613_CR264","doi-asserted-by":"crossref","unstructured":"Bergstr\u00f6m J, and Lindholm B (2000) What are the causes and consequences of the chronic inflammatory state in chronic dialysis patients?. Seminars in dialysis. Vol. 13. No. 3. Boston, MA, USA: Blackwell Science Inc","DOI":"10.1046\/j.1525-139x.2000.00044.x"},{"issue":"6","key":"4613_CR265","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1111\/bjh.15062","volume":"180","author":"CB Keragala","year":"2018","unstructured":"Keragala CB et al (2018) Haemostasis and innate immunity\u2013a complementary relationship: a review of the intricate relationship between coagulation and complement pathways. Br J Haematol 180(6):782\u2013798","journal-title":"Br J Haematol"},{"issue":"4","key":"4613_CR266","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.it.2007.02.006","volume":"28","author":"MM Markiewski","year":"2007","unstructured":"Markiewski MM et al (2007) Complement and coagulation: strangers or partners in crime? Trends Immunol 28(4):184\u2013192","journal-title":"Trends Immunol"},{"key":"4613_CR267","unstructured":"A Complex Interplay Exists Between Complement, Inflammation, and Coagulation. Understand CAD, Feb. 2023, https:\/\/www.understandcad.com\/about-cad#. Accessed 17 Mar 2025"},{"key":"4613_CR268","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3389\/fimmu.2018.00071","volume":"9","author":"F Poppelaars","year":"2018","unstructured":"Poppelaars F et al (2018) The complement system in dialysis: a forgotten story? Front Immunol 9:71","journal-title":"Front Immunol"},{"issue":"12","key":"4613_CR269","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.addr.2011.06.012","volume":"63","author":"KN Ekdahl","year":"2011","unstructured":"Ekdahl KN et al (2011) Innate immunity activation on biomaterial surfaces: a mechanistic model and coping strategies. Adv Drug Deliv Rev 63(12):1042\u20131050","journal-title":"Adv Drug Deliv Rev"},{"issue":"11","key":"4613_CR270","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.imbio.2012.07.012","volume":"217","author":"RA DeAngelis","year":"2012","unstructured":"DeAngelis RA et al (2012) Targeted complement inhibition as a promising strategy for preventing inflammatory complications in hemodialysis. Immunobiology 217(11):1097\u20131105","journal-title":"Immunobiology"},{"key":"4613_CR271","unstructured":"Gaya da Costa M (2019) Complement activation in chronic kidney disease and dialysis. [Thesis fully internal (DIV), University of Groningen]. Rijksuniversiteit Groningen."},{"key":"4613_CR272","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.jiec.2024.04.024","volume":"138","author":"Musawira Iftikhar","year":"2024","unstructured":"Iftikhar M, Othman MHD,  Imran Ullah Khan, Nurul I, Aniqa I, Sumarni M, Roziana K, Siti H, Sheikh AK, Mohd HP, Huda A,(2024) Future research perspectives in hemodialysis membrane technology. J Indus Eng Chem 138:72\u2013103. https:\/\/doi.org\/10.1016\/j.jiec.2024.04.024","journal-title":"Journal of Industrial and Engineering Chemistry"},{"key":"4613_CR273","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-323-52978-5.01001-6","author":"J Himmelfarb","year":"2018","unstructured":"Himmelfarb J, Ikizler TA (2018) Chronic Kidney Disease, Dialysis, and Transplantation: A Companion to Brenner and Rector\u2019s The Kidney. Elsevier. https:\/\/doi.org\/10.1016\/B978-0-323-52978-5.01001-6","journal-title":"Elsevier"},{"issue":"11","key":"4613_CR274","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1111\/all.14413","volume":"75","author":"EA Komi","year":"2020","unstructured":"Komi EA, Daniel et al (2020) Mast cells and complement system: ancient interactions between components of innate immunity. Allergy 75(11):2818\u20132828","journal-title":"Allergy"},{"issue":"6","key":"4613_CR275","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/j.ajpath.2020.02.006","volume":"190","author":"CB Xie","year":"2020","unstructured":"Xie CB, Jane-Wit D, Pober JS (2020) Complement membrane attack complex: new roles, mechanisms of action, and therapeutic targets. Am J Pathol 190(6):1138\u20131150","journal-title":"Am J Pathol"},{"issue":"10","key":"4613_CR276","doi-asserted-by":"crossref","first-page":"1900074","DOI":"10.1002\/bies.201900074","volume":"41","author":"DJ Doorduijn","year":"2019","unstructured":"Doorduijn DJ, Rooijakkers SHM, Heesterbeek DAC (2019) How the membrane attack complex damages the bacterial cell envelope and kills gram-negative bacteria. BioEssays 41(10):1900074","journal-title":"BioEssays"},{"key":"4613_CR277","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s00281-011-0280-x","volume":"34","author":"K Oikonomopoulou","year":"2012","unstructured":"Oikonomopoulou K, Ricklin D, Ward PA et al (2012) Interactions between coagulation and complement\u2014their role in inflammation. Semin Immunopathol 34:151\u2013165. https:\/\/doi.org\/10.1007\/s00281-011-0280-x","journal-title":"Semin Immunopathol"},{"issue":"2","key":"4613_CR278","doi-asserted-by":"crossref","first-page":"354","DOI":"10.3390\/ijms18020354","volume":"18","author":"P Dumnicka","year":"2017","unstructured":"Dumnicka P et al (2017) The interplay between inflammation, coagulation and endothelial injury in the early phase of acute pancreatitis: clinical implications. Int J Mol Sci 18(2):354","journal-title":"Int J Mol Sci"},{"issue":"2","key":"4613_CR279","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1542-4758.2007.00166.x","volume":"11","author":"KG FISCHER","year":"2007","unstructured":"FISCHER KG (2007) Essentials of anticoagulation in hemodialysis. Hemodial Int 11(2):178\u2013189","journal-title":"Hemodial Int"},{"issue":"1","key":"4613_CR280","first-page":"603","volume":"26","author":"RM Lindsay","year":"1980","unstructured":"Lindsay RM et al (1980) Blood surface interactions. ASAIO J 26(1):603\u2013610","journal-title":"ASAIO J"},{"issue":"1","key":"4613_CR281","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2741\/1780","volume":"11","author":"S Strukova","year":"2006","unstructured":"Strukova S (2006) Blood coagulation-dependent inflammation. coagulation-dependent inflammation and inflammation-dependent thrombosis. Front Biosci 11(1):59\u201380","journal-title":"Front Biosci"},{"issue":"4","key":"4613_CR282","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1365-2141.2005.05753.x","volume":"131","author":"CT Esmon","year":"2005","unstructured":"Esmon CT (2005) The interactions between inflammation and coagulation. Br J Haematol 131(4):417\u2013430","journal-title":"Br J Haematol"},{"key":"4613_CR283","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1007\/s00109-013-1074-5","volume":"91","author":"S Danckwardt","year":"2013","unstructured":"Danckwardt S, Hentze MW, Kulozik AE (2013) Pathologies at the nexus of blood coagulation and inflammation: thrombin in hemostasis, cancer, and beyond. J Mol Med 91:1257\u20131271","journal-title":"J Mol Med"},{"issue":"8","key":"4613_CR284","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.3390\/ijms22084283","volume":"22","author":"C Schl\u00f6mmer","year":"2021","unstructured":"Schl\u00f6mmer C, Brandtner A, Bachler M (2021) Antithrombin and its role in host defense and inflammation. Int J Mol Sci 22(8):4283","journal-title":"Int J Mol Sci"},{"key":"4613_CR285","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1016\/S0049-3848(10)70153-5","volume":"127","author":"J Pet\u00e4j\u00e4","year":"2011","unstructured":"Pet\u00e4j\u00e4 J (2011) Inflammation and coagulation. an overview. Thromb Res 127:S34\u2013S37","journal-title":"Thromb Res"},{"issue":"6","key":"4613_CR286","doi-asserted-by":"publisher","first-page":"151473","DOI":"10.1016\/j.semnephrol.2023.151473","volume":"43","author":"ME Matthias","year":"2023","unstructured":"Matthias ME, Peter V, Thomas V (2023) Clotting of the extracorporeal circuit in hemodialysis: beyond contact-activated coagulation. Semi Nephrol  43(6):151473. https:\/\/doi.org\/10.1016\/j.semnephrol.2023.151473","journal-title":"Semi Nephrol"},{"issue":"5","key":"4613_CR287","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nrneph.2017.17","volume":"13","author":"KN Ekdahl","year":"2017","unstructured":"Ekdahl KN et al (2017) Cardiovascular disease in haemodialysis: role of the intravascular innate immune system. Nat Rev Nephrol 13(5):285\u2013296","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"4613_CR288","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/ckj\/sfv137","volume":"9","author":"M Manani","year":"2016","unstructured":"Manani M, Sabrina et al (2016) Pro-inflammatory cytokines: a possible relationship with dialytic adequacy and serum albumin in peritoneal dialysis patients. Clin Kidney J 9(1):153\u2013157","journal-title":"Clin Kidney J"},{"issue":"1","key":"4613_CR289","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1080\/0886022X.2021.1871921","volume":"43","author":"J Yu","year":"2021","unstructured":"Yu J et al (2021) Pro-inflammatory cytokines as potential predictors for intradialytic hypotension. Ren Fail 43(1):198\u2013205","journal-title":"Ren Fail"},{"key":"4613_CR290","doi-asserted-by":"crossref","first-page":"S104","DOI":"10.1046\/j.1523-1755.2000.07613.x","volume":"58","author":"G Pertosa","year":"2000","unstructured":"Pertosa G et al (2000) Clinical relevance of cytokine production in hemodialysis. Kidney Int 58:S104\u2013S111","journal-title":"Kidney Int"},{"key":"4613_CR291","doi-asserted-by":"crossref","first-page":"692142","DOI":"10.3389\/fonc.2021.692142","volume":"11","author":"AER Kartikasari","year":"2021","unstructured":"Kartikasari AER et al (2021) Tumor-induced inflammatory cytokines and the emerging diagnostic devices for cancer detection and prognosis. Front Oncol 11:692142","journal-title":"Front Oncol"},{"issue":"6","key":"4613_CR292","doi-asserted-by":"crossref","first-page":"e13646","DOI":"10.1111\/acel.13646","volume":"21","author":"R Kandhaya-Pillai","year":"2022","unstructured":"Kandhaya-Pillai R et al (2022) TNF-\u03b1\/IFN-\u03b3 synergy amplifies senescence-associated inflammation and SARS-CoV-2 receptor expression via hyper-activated JAK\/STAT1. Aging Cell 21(6):e13646","journal-title":"Aging Cell"},{"issue":"2","key":"4613_CR293","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1159\/000046932","volume":"19","author":"P Stenvinkel","year":"2001","unstructured":"Stenvinkel P (2001) Malnutrition and chronic inflammation as risk factors for cardiovascular disease in chronic renal failure. Blood Purif 19(2):143\u2013151","journal-title":"Blood Purif"},{"issue":"5","key":"4613_CR294","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.semnephrol.2004.06.009","volume":"24","author":"A George","year":"2004","unstructured":"George A (2004) Kaysen, Inflammation: Cause of vascular disease and malnutrition in dialysis patients. Seminars in Nephrology 24(5):431\u2013436. https:\/\/doi.org\/10.1016\/j.semnephrol.2004.06.009","journal-title":"Seminars in Nephrology"},{"key":"4613_CR295","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s12291-008-0048-9","volume":"23","author":"P Rao","year":"2008","unstructured":"Rao P, Reddy GC, Kanagasabapathy AS (2008) Malnutrition-inflammation-atherosclerosis syndrome in chronic kidney disease. Indian J Clin Biochem 23:209\u2013217","journal-title":"Indian J Clin Biochem"},{"issue":"6","key":"4613_CR296","doi-asserted-by":"crossref","first-page":"Iii","DOI":"10.1097\/01.MAT.0000147958.87989.EB","volume":"50","author":"Q Yao","year":"2004","unstructured":"Yao Q et al (2004) Chronic systemic inflammation in dialysis patients: an update on causes and consequences. ASAIO J 50(6):Iii\u2013Ivii","journal-title":"ASAIO J"},{"issue":"5","key":"4613_CR297","doi-asserted-by":"crossref","first-page":"565","DOI":"10.3390\/pathogens10050565","volume":"10","author":"AA Rabaan","year":"2021","unstructured":"Rabaan AA et al (2021) Diverse immunological factors influencing pathogenesis in patients with COVID-19: a review on viral dissemination, immunotherapeutic options to counter cytokine storm and inflammatory responses. Pathogens 10(5):565","journal-title":"Pathogens"},{"key":"4613_CR298","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.3389\/fphar.2019.01192","volume":"10","author":"V Andrade-Oliveira","year":"2019","unstructured":"Andrade-Oliveira V et al (2019) Inflammation in renal diseases: new and old players. Front Pharmacol 10:1192","journal-title":"Front Pharmacol"},{"issue":"2","key":"4613_CR299","first-page":"77","volume":"8","author":"P-T Li","year":"2012","unstructured":"Li P-T, Chow KM (2012) Infectious complications in dialysis\u2014epidemiology and outcomes. Nat Rev Nephrol 8(2):77\u201388","journal-title":"Nat Rev Nephrol"},{"issue":"7","key":"4613_CR300","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/j.ekir.2021.04.023","volume":"6","author":"P Stenvinkel","year":"2021","unstructured":"Stenvinkel P et al (2021) Chronic inflammation in chronic kidney disease progression: role of Nrf2. Kidney Int Rep 6(7):1775\u20131787","journal-title":"Kidney Int Rep"},{"issue":"6","key":"4613_CR301","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1038\/ki.2012.439","volume":"83","author":"S Ruiz","year":"2013","unstructured":"Ruiz S et al (2013) Targeting the transcription factor Nrf2 to ameliorate oxidative stress and inflammation in chronic kidney disease. Kidney Int 83(6):1029\u20131041","journal-title":"Kidney Int"},{"issue":"2","key":"4613_CR302","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/S0272-6386(03)00653-X","volume":"42","author":"M Danielski","year":"2003","unstructured":"Danielski M et al (2003) Linkage of hypoalbuminemia, inflammation, and oxidative stress in patients receiving maintenance hemodialysis therapy. Am J Kidney Dis 42(2):286\u2013294","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"4613_CR303","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1111\/j.1523-1755.2004.00656.x","volume":"65","author":"LB Pupim","year":"2004","unstructured":"Pupim LB et al (2004) Influence of initiation of maintenance hemodialysis on biomarkers of inflammation and oxidative stress. Kidney Int 65(6):2371\u20132379","journal-title":"Kidney Int"},{"issue":"6","key":"4613_CR304","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1053\/ajkd.2001.29280","volume":"38","author":"MA Spittle","year":"2001","unstructured":"Spittle MA et al (2001) Oxidative stress and inflammation in hemodialysis patients. Am J Kidney Dis 38(6):1408\u20131413","journal-title":"Am J Kidney Dis"},{"issue":"14\u201315","key":"4613_CR305","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.clinbiochem.2011.06.988","volume":"44","author":"C Libetta","year":"2011","unstructured":"Libetta C et al (2011) Oxidative stress and inflammation: implications in uremia and hemodialysis. Clin Biochem 44(14\u201315):1189\u20131198","journal-title":"Clin Biochem"},{"issue":"1","key":"4613_CR306","doi-asserted-by":"crossref","first-page":"3081856","DOI":"10.1155\/2017\/3081856","volume":"2017","author":"V Liakopoulos","year":"2017","unstructured":"Liakopoulos V et al (2017) Oxidative stress in hemodialysis patients: a review of the literature. Oxidative Med Cell Longev 2017(1):3081856","journal-title":"Oxidative Med Cell Longev"},{"issue":"8","key":"4613_CR307","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1097\/01.TP.0000157773.96534.29","volume":"79","author":"EM Simmons","year":"2005","unstructured":"Simmons EM et al (2005) Effect of renal transplantation on biomarkers of inflammation and oxidative stress in end-stage renal disease patients. Transplantation 79(8):914\u2013919","journal-title":"Transplantation"},{"issue":"4","key":"4613_CR308","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1159\/000245938","volume":"55","author":"MF Elshamaa","year":"2009","unstructured":"Elshamaa MF et al (2009) Oxidative stress markers and C-reactive protein in pediatric patients on hemodialysis. Ann Nutr Metab 55(4):309\u2013316","journal-title":"Ann Nutr Metab"},{"key":"4613_CR309","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1007\/s00726-010-0773-2","volume":"42","author":"R Ramasamy","year":"2012","unstructured":"Ramasamy R, Yan SF, Schmidt AM (2012) Advanced glycation endproducts: from precursors to RAGE: round and round we go. Amino Acids 42:1151\u20131161","journal-title":"Amino Acids"},{"issue":"14","key":"4613_CR310","doi-asserted-by":"crossref","first-page":"7236","DOI":"10.3390\/ijerph18147236","volume":"18","author":"J Salazar","year":"2021","unstructured":"Salazar J et al (2021) Advanced glycation end products: new clinical and molecular perspectives. Int J Environ Res Public Health 18(14):7236","journal-title":"Int J Environ Res Public Health"},{"key":"4613_CR311","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.biocel.2016.06.016","volume":"81","author":"NL Reynaert","year":"2016","unstructured":"Reynaert NL et al (2016) Advanced glycation end products and their receptor in age-related, non-communicable chronic inflammatory diseases; overview of clinical evidence and potential contributions to disease. Int J Biochem Cell Biol 81:403\u2013418","journal-title":"Int J Biochem Cell Biol"},{"key":"4613_CR312","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1007\/s00125-009-1458-9","volume":"52","author":"A Bierhaus","year":"2009","unstructured":"Bierhaus A, Nawroth PP (2009) Multiple levels of regulation determine the role of the receptor for AGE (RAGE) as common soil in inflammation, immune responses and diabetes mellitus and its complications. Diabetologia 52:2251\u20132263","journal-title":"Diabetologia"},{"issue":"8","key":"4613_CR313","doi-asserted-by":"crossref","first-page":"743","DOI":"10.2174\/156652407783220714","volume":"7","author":"AM Schmidt","year":"2007","unstructured":"Schmidt AM et al (2007) Receptor for AGE (RAGE): weaving tangled webs within the inflammatory response. Curr Mol Med 7(8):743\u2013751","journal-title":"Curr Mol Med"},{"key":"4613_CR314","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00109-009-0439-2","volume":"87","author":"SF Yan","year":"2009","unstructured":"Yan SF, Ramasamy R, Schmidt AM (2009) Receptor for AGE (RAGE) and its ligands\u2014cast into leading roles in diabetes and the inflammatory response. J Mol Med 87:235\u2013247","journal-title":"J Mol Med"},{"issue":"1","key":"4613_CR315","first-page":"16","volume":"1","author":"HS Cheng","year":"2017","unstructured":"Cheng HS, Ton SH, Kadir KA (2017) Therapeutic agents targeting at AGE-RAGE axis for the treatment of diabetes and cardiovascular disease: a review of clinical evidence. Clin Diabetes Res 1(1):16\u201334","journal-title":"Clin Diabetes Res"},{"issue":"2","key":"4613_CR316","first-page":"132","volume":"4","author":"MM Roorda","year":"2017","unstructured":"Roorda MM (2017) Therapeutic interventions against accumulation of advanced glycation end products (AGEs). Glycative Stress Res 4(2):132\u2013143","journal-title":"Glycative Stress Res"},{"issue":"1","key":"4613_CR317","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.nefroe.2017.01.017","volume":"37","author":"SC Guldris","year":"2017","unstructured":"Guldris SC, Parra EG, Amen\u00f3s AC (2017) Gut microbiota in chronic kidney disease. Nefrolog\u00eda (English Edition) 37(1):9\u201319","journal-title":"Nefrolog\u00eda (English Edition)"},{"key":"4613_CR318","doi-asserted-by":"crossref","first-page":"579386","DOI":"10.3389\/fcimb.2021.579386","volume":"11","author":"D Luo","year":"2021","unstructured":"Luo D et al (2021) The effects of hemodialysis and peritoneal dialysis on the gut microbiota of end-stage renal disease patients, and the relationship between gut microbiota and patient prognoses. Front Cell Infect Microbiol 11:579386","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"4613_CR319","first-page":"26191","volume":"26","author":"S Carding","year":"2015","unstructured":"Carding S et al (2015) Dysbiosis of the gut microbiota in disease. Microb Ecol Health Dis 26(1):26191","journal-title":"Microb Ecol Health Dis"},{"issue":"2","key":"4613_CR320","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1159\/000381990","volume":"130","author":"WL Lau","year":"2015","unstructured":"Lau WL, Kalantar-Zadeh K, Vaziri ND (2015) The gut as a source of inflammation in chronic kidney disease. Nephron 130(2):92\u201398","journal-title":"Nephron"},{"issue":"5","key":"4613_CR321","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3390\/toxins12050340","volume":"12","author":"M Girndt","year":"2020","unstructured":"Girndt M, Trojanowicz B, Ulrich C (2020) Monocytes in uremia. Toxins 12(5):340","journal-title":"Toxins"},{"key":"4613_CR322","doi-asserted-by":"crossref","first-page":"100299","DOI":"10.1016\/j.impact.2021.100299","volume":"21","author":"S Daneshamouz","year":"2021","unstructured":"Daneshamouz S et al (2021) Protein-bound uremic toxins (PBUTs) in chronic kidney disease (CKD) patients: production pathway, challenges and recent advances in renal PBUTs clearance. NanoImpact 21:100299","journal-title":"NanoImpact"},{"key":"4613_CR323","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s11255-017-1748-y","volume":"50","author":"MB Stockler-Pinto","year":"2018","unstructured":"Stockler-Pinto MB et al (2018) From bench to the hemodialysis clinic: protein-bound uremic toxins modulate NF-\u03baB\/Nrf2 expression. Int Urol Nephrol 50:347\u2013354","journal-title":"Int Urol Nephrol"},{"key":"4613_CR324","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.2147\/DDDT.S364069","volume":"1","author":"X Li","year":"2022","unstructured":"Li X et al (2022) Effects of uremic clearance granules on p38 MAPK\/NF-\u03baB signaling pathway, microbial and metabolic profiles in end-stage renal disease rats receiving peritoneal dialysis. Drug Des Dev Ther 1:2529\u20132544","journal-title":"Drug Des Dev Ther"},{"issue":"3","key":"4613_CR325","doi-asserted-by":"crossref","first-page":"285","DOI":"10.5152\/eurasianjmed.2019.18434","volume":"51","author":"C Toprak","year":"2019","unstructured":"Toprak C, Yigitaslan S (2019) Alagebrium and complications of diabetes mellitus. Eurasian J Med 51(3):285","journal-title":"Eurasian J Med"},{"issue":"5","key":"4613_CR326","doi-asserted-by":"crossref","first-page":"361","DOI":"10.3390\/toxins13050361","volume":"13","author":"K Taguchi","year":"2021","unstructured":"Taguchi K et al (2021) Dysbiosis-related advanced glycation endproducts and trimethylamine N-oxide in chronic kidney disease. Toxins 13(5):361","journal-title":"Toxins"},{"issue":"1","key":"4613_CR327","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4161\/epi.27473","volume":"9","author":"VJ Peschansky","year":"2014","unstructured":"Peschansky VJ, Wahlestedt C (2014) Non-coding RNAs as direct and indirect modulators of epigenetic regulation. Epigenetics 9(1):3\u201312","journal-title":"Epigenetics"},{"issue":"12","key":"4613_CR328","doi-asserted-by":"crossref","first-page":"6264","DOI":"10.3390\/ijms22126264","volume":"22","author":"P de la Cruz-Ojeda","year":"2021","unstructured":"de la Cruz-Ojeda P et al (2021) Role of nitric oxide in gene expression regulation during cancer: epigenetic modifications and non-coding RNAs. Int J Mol Sci 22(12):6264","journal-title":"Int J Mol Sci"},{"issue":"8","key":"4613_CR329","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/nrcardio.2015.71","volume":"12","author":"CM Greco","year":"2015","unstructured":"Greco CM, Condorelli G (2015) Epigenetic modifications and noncoding RNAs in cardiac hypertrophy and failure. Nat Rev Cardiol 12(8):488\u2013497","journal-title":"Nat Rev Cardiol"},{"issue":"2","key":"4613_CR330","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1053\/j.ajkd.2013.10.047","volume":"63","author":"SS Badal","year":"2014","unstructured":"Badal SS, Danesh FR (2014) New insights into molecular mechanisms of diabetic kidney disease. Am J Kidney Dis 63(2):S63\u2013S83","journal-title":"Am J Kidney Dis"},{"key":"4613_CR331","doi-asserted-by":"crossref","first-page":"205435811983908","DOI":"10.1177\/2054358119839080","volume":"6","author":"C Lamarche","year":"2019","unstructured":"Lamarche C, Iliuta I-A, Kitzler T (2019) Infectious disease risk in dialysis patients: a transdisciplinary approach. Can J Kidney Health Dis 6:2054358119839080","journal-title":"Can J Kidney Health Dis"},{"issue":"2","key":"4613_CR332","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1492-7535.2004.01085.x","volume":"8","author":"Q Yao","year":"2004","unstructured":"Yao Q, Lindholm B, Stenvinkel P (2004) Inflammation as a cause of malnutrition, atherosclerotic cardiovascular disease, and poor outcome in hemodialysis patients. Hemodial Int 8(2):118\u2013129","journal-title":"Hemodial Int"},{"issue":"5","key":"4613_CR333","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2174\/1871528110908050369","volume":"8","author":"V Filiopoulos","year":"2009","unstructured":"Filiopoulos V, Vlassopoulos D (2009) Inflammatory syndrome in chronic kidney disease: pathogenesis and influence on outcomes. Inflamm Allergy Drug Targets 8(5):369\u2013382","journal-title":"Inflamm Allergy Drug Targets"},{"issue":"8","key":"4613_CR334","doi-asserted-by":"crossref","first-page":"752","DOI":"10.3390\/antiox9080752","volume":"9","author":"A Podkowi\u0144ska","year":"2020","unstructured":"Podkowi\u0144ska A, Formanowicz D (2020) Chronic kidney disease as oxidative stress-and inflammatory-mediated cardiovascular disease. Antioxidants 9(8):752","journal-title":"Antioxidants"},{"key":"4613_CR335","doi-asserted-by":"crossref","unstructured":"Rao M, Jaber BL, and Balakrishnan VS (2006) Unresolved issues in dialysis inflammatory biomarkers and cardiovascular risk association or cause and effect?. Seminars in dialysis. Blackwell Publishing, USA, 19 2: pp 129-135","DOI":"10.1111\/j.1525-139X.2006.00138.x"},{"issue":"13","key":"4613_CR336","doi-asserted-by":"crossref","first-page":"7108","DOI":"10.3390\/ijms23137108","volume":"23","author":"J Rysz","year":"2022","unstructured":"Rysz J et al (2022) Are alterations in DNA methylation related to CKD development? Int J Mol Sci 23(13):7108","journal-title":"Int J Mol Sci"},{"issue":"11","key":"4613_CR337","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1016\/j.yexcr.2006.03.006","volume":"312","author":"M Karimi","year":"2006","unstructured":"Karimi M et al (2006) LUMA (LUminometric Methylation Assay)\u2014a high throughput method to the analysis of genomic DNA methylation. Exp Cell Res 312(11):1989\u20131995","journal-title":"Exp Cell Res"},{"key":"4613_CR338","unstructured":"Karin L (2016) Ageing and inflammation with focus on end-stage renal diseases : genetic and epigenetic factors. Karolinska Institutet. Thesis. https:\/\/hdl.handle.net\/10616\/45143"},{"issue":"3","key":"4613_CR339","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/nrneph.2011.2","volume":"7","author":"CL Meuwese","year":"2011","unstructured":"Meuwese CL et al (2011) Monitoring of inflammation in patients on dialysis: forewarned is forearmed. Nat Rev Nephrol 7(3):166\u2013176","journal-title":"Nat Rev Nephrol"},{"issue":"8","key":"4613_CR340","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1093\/ndt\/14.8.1956","volume":"14","author":"K Iseki","year":"1999","unstructured":"Iseki K et al (1999) Serum C-reactive protein (CRP) and risk of death in chronic dialysis patients. Nephrol Dial Transplant 14(8):1956\u20131960","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"4613_CR341","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1093\/ndt\/17.6.1105","volume":"17","author":"O Ortega","year":"2002","unstructured":"Ortega O et al (2002) Significance of high C-reactive protein levels in pre-dialysis patients. Nephrol Dial Transplant 17(6):1105\u20131109","journal-title":"Nephrol Dial Transplant"},{"issue":"1534","key":"4613_CR342","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.1098\/rstb.2009.0125","volume":"364","author":"BM Turner","year":"2009","unstructured":"Turner BM (2009) Epigenetic responses to environmental change and their evolutionary implications. Philos Trans R Soc B Biol Sci 364(1534):3403\u20133418","journal-title":"Philos Trans R Soc B Biol Sci"},{"issue":"2","key":"4613_CR343","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/jcp.21678","volume":"219","author":"GP Delcuve","year":"2009","unstructured":"Delcuve GP, Rastegar M, Davie JR (2009) Epigenetic control. J Cell Physiol 219(2):243\u2013250","journal-title":"J Cell Physiol"},{"issue":"3","key":"4613_CR344","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jaci.2004.01.752","volume":"113","author":"D Vercelli","year":"2004","unstructured":"Vercelli D (2004) Genetics, epigenetics, and the environment: switching, buffering, releasing. J Allergy Clin Immunol 113(3):381\u2013386","journal-title":"J Allergy Clin Immunol"},{"key":"4613_CR345","first-page":"9","volume":"15","author":"M Zakir","year":"2023","unstructured":"Zakir M et al (2023) Cardiovascular complications of diabetes: from microvascular to macrovascular pathways. Cureus 15:9","journal-title":"Cureus"},{"issue":"11","key":"4613_CR346","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/s41581-018-0054-y","volume":"14","author":"N Perico","year":"2018","unstructured":"Perico N et al (2018) Maternal and environmental risk factors for neonatal AKI and its long-term consequences. Nat Rev Nephrol 14(11):688\u2013703","journal-title":"Nat Rev Nephrol"},{"issue":"16","key":"4613_CR347","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.3390\/nu15163609","volume":"15","author":"A Mocanu","year":"2023","unstructured":"Mocanu A et al (2023) Exploring a complex interplay: kidney-gut axis in pediatric chronic kidney disease. Nutrients 15(16):3609","journal-title":"Nutrients"},{"issue":"1","key":"4613_CR348","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/hdy.2010.54","volume":"105","author":"ER Gibney","year":"2010","unstructured":"Gibney ER, Nolan CM (2010) Epigenetics and gene expression. Heredity 105(1):4\u201313","journal-title":"Heredity"},{"issue":"3","key":"4613_CR349","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/ng1089","volume":"33","author":"R Jaenisch","year":"2003","unstructured":"Jaenisch R, Bird A (2003) Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet 33(3):245\u2013254","journal-title":"Nat Genet"},{"issue":"5","key":"4613_CR350","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/humupd\/dmz017","volume":"25","author":"MJ Xavier","year":"2019","unstructured":"Xavier MJ et al (2019) Transgenerational inheritance: how impacts to the epigenetic and genetic information of parents affect offspring health. Hum Reprod Update 25(5):519\u2013541","journal-title":"Hum Reprod Update"},{"issue":"42","key":"4613_CR351","doi-asserted-by":"crossref","first-page":"32512","DOI":"10.1074\/jbc.M110.150490","volume":"285","author":"SK Rao","year":"2010","unstructured":"Rao SK et al (2010) Pro-inflammatory genes as biomarkers and therapeutic targets in oral squamous cell carcinoma. J Biol Chem 285(42):32512\u201332521","journal-title":"J Biol Chem"},{"issue":"1","key":"4613_CR352","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1038\/s41467-017-01297-7","volume":"8","author":"AY Chu","year":"2017","unstructured":"Chu AY et al (2017) Epigenome-wide association studies identify DNA methylation associated with kidney function. Nat Commun 8(1):1286","journal-title":"Nat Commun"},{"issue":"1","key":"4613_CR353","doi-asserted-by":"crossref","first-page":"7891","DOI":"10.1038\/s41467-022-34963-6","volume":"13","author":"LJ Smyth","year":"2022","unstructured":"Smyth LJ et al (2022) Epigenome-wide meta-analysis identifies DNA methylation biomarkers associated with diabetic kidney disease. Nat Commun 13(1):7891","journal-title":"Nat Commun"},{"issue":"1","key":"4613_CR354","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s13148-021-01081-x","volume":"13","author":"LJ Smyth","year":"2021","unstructured":"Smyth LJ et al (2021) Assessment of differentially methylated loci in individuals with end-stage kidney disease attributed to diabetic kidney disease: an exploratory study. Clin Epigenetics 13(1):99","journal-title":"Clin Epigenetics"},{"issue":"1","key":"4613_CR355","doi-asserted-by":"crossref","first-page":"7174","DOI":"10.1038\/s41467-021-27234-3","volume":"12","author":"P Schlosser","year":"2021","unstructured":"Schlosser P et al (2021) Meta-analyses identify DNA methylation associated with kidney function and damage. Nat Commun 12(1):7174","journal-title":"Nat Commun"},{"issue":"1","key":"4613_CR356","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1038\/s41467-023-37837-7","volume":"14","author":"KY Li","year":"2023","unstructured":"Li KY et al (2023) DNA methylation markers for kidney function and progression of diabetic kidney disease. Nat Commun 14(1):2543","journal-title":"Nat Commun"},{"issue":"7","key":"4613_CR357","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1080\/15592294.2020.1819666","volume":"16","author":"A Dritsoula","year":"2021","unstructured":"Dritsoula A et al (2021) Epigenome-wide methylation profile of chronic kidney disease-derived arterial DNA uncovers novel pathways in disease-associated cardiovascular pathology. Epigenetics 16(7):718\u2013728","journal-title":"Epigenetics"},{"issue":"9","key":"4613_CR358","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/s41569-018-0064-2","volume":"15","author":"L Ferrucci","year":"2018","unstructured":"Ferrucci L, Fabbri E (2018) Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty. Nat Rev Cardiol 15(9):505\u2013522","journal-title":"Nat Rev Cardiol"},{"issue":"12","key":"4613_CR359","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1253\/circj.CJ-11-1184","volume":"75","author":"I Manabe","year":"2011","unstructured":"Manabe I (2011) Chronic inflammation links cardiovascular, metabolic and renal diseases. Circ J 75(12):2739\u20132748","journal-title":"Circ J"},{"issue":"1","key":"4613_CR360","doi-asserted-by":"crossref","first-page":"14808","DOI":"10.1038\/s41598-020-71755-8","volume":"10","author":"H Westphalen","year":"2020","unstructured":"Westphalen H et al (2020) Case studies of clinical hemodialysis membranes: influences of membrane morphology and biocompatibility on uremic blood-membrane interactions and inflammatory biomarkers. Sci Rep 10(1):14808","journal-title":"Sci Rep"},{"issue":"15","key":"4613_CR361","doi-asserted-by":"crossref","first-page":"5090","DOI":"10.1039\/D0AN00633E","volume":"145","author":"RL Pinals","year":"2020","unstructured":"Pinals RL et al (2020) Engineering at the nano-bio interface: harnessing the protein corona towards nanoparticle design and function. Analyst 145(15):5090\u20135112","journal-title":"Analyst"},{"issue":"8","key":"4613_CR362","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1039\/C8BM00518D","volume":"6","author":"M Bernard","year":"2018","unstructured":"Bernard M et al (2018) Biocompatibility of polymer-based biomaterials and medical devices\u2013regulations, in vitro screening and risk-management. Biomater Sci 6(8):2025\u20132053","journal-title":"Biomater Sci"},{"issue":"5","key":"4613_CR363","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1159\/000095902","volume":"26","author":"J Rysz","year":"2006","unstructured":"Rysz J et al (2006) Increased levels of soluble TNF-\u03b1 receptors and cellular adhesion molecules in patients undergoing bioincompatible hemodialysis. Am J Nephrol 26(5):437\u2013444","journal-title":"Am J Nephrol"},{"issue":"2","key":"4613_CR364","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.smim.2007.11.004","volume":"20","author":"M James","year":"2008","unstructured":"James M (2008) Anderson, Analiz Rodriguez, David T. Chang, Foreign body reaction to biomaterials, Seminars in Immunology 20(2):86\u2013100. https:\/\/doi.org\/10.1016\/j.smim.2007.11.004","journal-title":"Chang, Foreign body reaction to biomaterials, Seminars in Immunology"},{"key":"4613_CR365","doi-asserted-by":"crossref","first-page":"727075","DOI":"10.3389\/fcell.2021.727075","volume":"9","author":"K You","year":"2021","unstructured":"You K et al (2021) Tumor necrosis factor alpha signaling and organogenesis. Front Cell Dev Biol 9:727075","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"4613_CR366","first-page":"1","volume":"2","author":"T Liu","year":"2017","unstructured":"Liu T et al (2017) NF-\u03baB signaling in inflammation. Signal Transduct Target Ther 2(1):1\u20139","journal-title":"Signal Transduct Target Ther"},{"issue":"6","key":"4613_CR367","doi-asserted-by":"crossref","first-page":"a001651","DOI":"10.1101\/cshperspect.a001651","volume":"1","author":"T Lawrence","year":"2009","unstructured":"Lawrence T (2009) The nuclear factor NF-\u03baB pathway in inflammation. Cold Spring Harb Perspect Biol 1(6):a001651","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"11","key":"4613_CR368","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/S1567-5769(02)00058-9","volume":"2","author":"T Wang","year":"2002","unstructured":"Wang T, Zhang X, Li JJ (2002) The role of NF-\u03baB in the regulation of cell stress responses. Int Immunopharmacol 2(11):1509\u20131520","journal-title":"Int Immunopharmacol"},{"issue":"6","key":"4613_CR369","doi-asserted-by":"crossref","first-page":"660","DOI":"10.3892\/br.2016.781","volume":"5","author":"SN Uwaezuoke","year":"2016","unstructured":"Uwaezuoke SN et al (2016) Chronic kidney disease in children and the role of epigenetics: future therapeutic trajectories. Biomed Rep 5(6):660\u2013664","journal-title":"Biomed Rep"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-025-04613-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-025-04613-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-025-04613-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T18:09:21Z","timestamp":1761847761000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-025-04613-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,25]]},"references-count":369,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4613"],"URL":"https:\/\/doi.org\/10.1007\/s11255-025-04613-z","relation":{},"ISSN":["1573-2584"],"issn-type":[{"type":"electronic","value":"1573-2584"}],"subject":[],"published":{"date-parts":[[2025,6,25]]},"assertion":[{"value":"9 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Dr. Amira Abdelrasoul, the principal investigator of the project, obtained Research Ethics Approval and Operational Approval to conduct this research in the Saskatchewan Health Authority. She is responsible for regulatory approvals that pertain to this project, and for ensuring the project was conducted according to the governing law.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}